Details of Drug

Drug General Information (ID: D0639)
Drug Name	Felbamate
Drug Type	Small molecule
Drug Synonymous	Felbamato; Felbamatum; Felbamyl; Felbatol; Taloxa; Essex brand of felbamate; Felbamato [Spanish]; Felbamatum [Latin]; Schering brand of felbamate; F 0778; W 554; Wallace brand 1 of felbamate; Wallace brand 2 of felbamate; ADD-03055; Carbamic acid 2-phenyltrimethylene ester; Felbamate [USAN:INN]; Felbatol (TN); Schering-Plough brand of felbamate; W-554; Carbamic acid, 2-phenyltrimethylene ester; Felbamate (USAN/INN); (3-carbamoyloxy-2-phenyl-propyl) carbamate; (3-carbamoyloxy-2-phenylpropyl) carbamate; 1,3-Propanediol, 2-phenyl-, dicarbamate; 2-Phenyl-1,3-propanediol dicarbamate; 2-Phenylpropane-1,3-diyl dicarbamate Click to Show/Hide
Disease Class	8A61-8A6Z: Epilepsy/seizure
Therapeutic Class	Anticonvulsants
Structure
Structure	3D Structure		2D Structure
Formula	C11H14N2O4
InChI	1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)
InChIKey	WKGXYQFOCVYPAC-UHFFFAOYSA-N
Canonical SMILES	C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N
External Link
	Pubchem ID	3331
	CAS Number	25451-15-4
	CHEBI ID	4995
	TTD ID	D05KON
	INTEDE ID	DR0684

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM003 Complex formation BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM026 Increased metabolism (Unspecific) BM038 Additive CNS depression effects BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM055 Increased risk of hepatotoxicity BM067 Increased risk of hyponatremia BM072 Increased risk of nephrotoxicity BM087 Antagonize the effect of antiepileptic agents BM089 Antagonize the effect of antihypertensive agents
Relation Graph

Full list of drugs interacting with Felbamate
Affected gastrointestinal absorption
	Complex formation					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0381		Colesevelam	C31H67Cl3N4O	160051	Moderate		Inter Info	[61], [165]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 8
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[17], [18], [19]
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[133], [134], [135], [136], [137], [138]
D0364		Clopidogrel	C16H16ClNO2S	60606	Moderate		Inter Info	[146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [159], [160], [161], [162], [163], [164]
D0481		Dicoumarol	C19H12O6	54676038	Moderate		Inter Info	[347], [348], [349]
D0087		Anisindione	C16H12O3	2197	Moderate		Inter Info	[347], [348], [349]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[446], [447], [448], [449], [450], [451], [452], [453], [454]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[61], [58], [20], [477], [478], [479], [480], [481], [482], [483], [484], [364], [485]
D1711		Warfarin	C19H16O4	54678486	Moderate		Inter Info	[347], [348], [349]
	CYP450 enzyme induction					Drug Num: 189
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0626		Etonogestrel	C22H28O2	6917715	Major		Inter Info	[25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0485		Dienogest	C20H25NO2	68861	Major		Inter Info	[28], [36], [47]
D0536		Drospirenone	C24H30O3	68873	Major		Inter Info	[25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0619		Ethinylestradiol	C20H24O2	5991	Major		Inter Info	[28], [36], [47]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[64], [65]
D0959		Lumateperone	C24H28FN3O	21302490	Major		Inter Info	[67]
D1011		Mestranol	C21H26O2	6291	Major		Inter Info	[28], [36], [47]
D1156		Norgestimate	C23H31NO3	6540478	Major		Inter Info	[28], [36], [47]
D1157		Norgestrel	C21H28O2	13109	Major		Inter Info	[25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D0922		Levonorgestrel	C21H28O2	13109	Major		Inter Info	[25], [26], [27], [28], [29], [30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57]
D1154		Norethisterone	C20H26O2	6230	Major		Inter Info	[28], [36], [47]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[72]
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D0100		Aprepitant	C23H21F7N4O3	135413536	Moderate		Inter Info	[95], [96]
D0222		Buspirone	C21H31N5O2	2477	Moderate		Inter Info	[110], [111], [112]
D0226		Butorphanol	C21H29NO2	5361092	Moderate		Inter Info	[113], [114], [115], [58], [20], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [94], [127], [128]
D0233		Calcifediol	C27H44O2	5283731	Moderate		Inter Info	[129], [130], [131], [132]
D0234		Calcitriol	C27H44O3	5280453	Moderate		Inter Info	[129], [130], [131], [132]
D0268		Caspofungin	C52H88N10O15	2826718	Moderate		Inter Info	[139]
D0328		Cholecalciferol	C27H44O	5280795	Moderate		Inter Info	[129], [130], [131], [132]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[166]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[167], [168]
D0494		Dihydroergotamine	C33H37N5O5	10531	Moderate		Inter Info	[58], [20], [350]
D0591		Ergocalciferol	C28H44O	5280793	Moderate		Inter Info	[129], [130], [131], [132]
D0593		Ergotamine	C33H35N5O5	8223	Moderate		Inter Info	[58], [20], [350]
D0595		Erlotinib	C22H23N3O4	176870	Moderate		Inter Info	[370], [371]
D0606		Estradiol	C18H24O2	5757	Moderate		Inter Info	[25], [372], [26], [373], [27], [29], [374], [375], [376], [377], [30], [31], [378], [32], [379], [34], [380], [35], [38], [381], [382], [383], [40], [42], [43], [384], [44], [385], [386], [387], [388], [45], [389], [390], [391], [392], [393], [56], [394], [395], [396], [397], [398], [399], [57], [400], [401]
D0607		Estradiol (topical)	C18H24O2	5757	Moderate		Inter Info	[27], [379], [395]
D0609		Estrone	C18H22O2	5870	Moderate		Inter Info	[25], [372], [26], [373], [27], [29], [374], [375], [376], [377], [30], [31], [378], [32], [379], [34], [380], [35], [38], [381], [382], [383], [40], [42], [43], [384], [44], [385], [386], [387], [388], [45], [389], [390], [391], [392], [393], [56], [394], [395], [396], [397], [398], [399], [57], [400], [401]
D0612		Eszopiclone	C17H17ClN6O3	969472	Moderate		Inter Info	[402]
D0006		Abemaciclib	C27H32F2N8	46220502	Moderate		Inter Info	[406]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[407]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[408]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[409], [410], [411], [136], [412], [413], [414], [356]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[415]
D0099		Apremilast	C22H24N2O7S	11561674	Moderate		Inter Info	[416]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[417]
D0106		Armodafinil	C15H15NO2S	9690109	Moderate		Inter Info	[418], [419]
D0108		Artemether	C16H26O5	68911	Moderate		Inter Info	[58], [20], [420]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[421], [422], [423], [424], [425]
D0128		Avanafil	C23H26ClN7O3	9869929	Moderate		Inter Info	[426]
D0129		Avapritinib	C26H27FN10	118023034	Moderate		Inter Info	[20], [427]
D0133		Axitinib	C22H18N4OS	6450551	Moderate		Inter Info	[428], [429]
D0161		Benzhydrocodone	C25H25NO4	49836084	Moderate		Inter Info	[114], [119], [128]
D0181		Bictegravir	C21H18F3N3O5	90311989	Moderate		Inter Info	[20], [431], [432]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[433], [434]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[435]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[58], [20], [438]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[439]
D0230		Cabozantinib	C28H24FN3O5	25102847	Moderate		Inter Info	[440], [441]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[443]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Moderate		Inter Info	[20], [444]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[445]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Moderate		Inter Info	[455]
D0389		Copanlisib	C23H28N8O4	135565596	Moderate		Inter Info	[456]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[457], [20], [458]
D0425		Darolutamide	C19H19ClN6O2	67171867	Moderate		Inter Info	[459]
D0426		Darunavir	C27H37N3O7S	213039	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[58], [20], [460]
D0495		Dihydrotachysterol	C28H46O	5311071	Moderate		Inter Info	[129], [130], [131], [132]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[461], [462], [463], [464], [465]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Moderate		Inter Info	[466], [467]
D0527		Doxercalciferol	C28H44O2	5281107	Moderate		Inter Info	[129], [130], [131], [132]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[20], [468], [469], [470]
D0534		Dronedarone	C31H44N2O5S	208898	Moderate		Inter Info	[471]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[472]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[473]
D0559		Eliglustat	C23H36N2O4	23652731	Moderate		Inter Info	[474]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[475]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[476]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[409], [410], [411], [136], [412], [413], [414], [356]
D0592		Ergometrine	C19H23N3O2	443884	Moderate		Inter Info	[58], [20], [350]
D0605		Esterified estrogens	NA	NA	Moderate		Inter Info	[25], [372], [26], [373], [27], [29], [374], [375], [376], [377], [30], [31], [378], [32], [379], [34], [380], [35], [38], [381], [382], [383], [40], [42], [43], [384], [44], [385], [386], [387], [388], [45], [389], [390], [391], [392], [393], [56], [394], [395], [396], [397], [398], [399], [57], [400], [401]
D0610		Estrone sulfate	C18H22O5S	3001028	Moderate		Inter Info	[27], [379], [395]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[487]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[58], [20], [488]
D0630		Exemestane	C20H24O2	60198	Moderate		Inter Info	[489]
D0655		Fesoterodine	C26H37NO3	6918558	Moderate		Inter Info	[490]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[492]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[495]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[499]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Moderate		Inter Info	[500]
D0739		Grazoprevir	C38H50N6O9S	44603531	Moderate		Inter Info	[501]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[20], [502], [503]
D0772		Hydrocodone	C18H21NO3	5284569	Moderate		Inter Info	[113], [114], [115], [58], [20], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [94], [127], [128]
D0785		Ibrutinib	C25H24N6O2	24821094	Moderate		Inter Info	[504]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[506]
D0868		Ivabradine	C27H36N2O5	132999	Moderate		Inter Info	[20], [507]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[508], [509], [510], [511]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[512]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[513]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[58], [20], [514]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[58], [20], [515]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[517]
D0901		Lemborexant	C22H20F2N4O2	56944144	Moderate		Inter Info	[58], [518]
D0930		Linagliptin	C25H28N8O2	10096344	Moderate		Inter Info	[522]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[523]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Moderate		Inter Info	[409], [412], [356]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[524]
D0965		Macimorelin	C26H30N6O3	9804938	Moderate		Inter Info	[525]
D0966		Macitentan	C19H20Br2N6O4S	16004692	Moderate		Inter Info	[526], [527]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[528], [529]
D1104		Naloxegol	C34H53NO11	56959087	Moderate		Inter Info	[530]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[531]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[58], [20], [533]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[113], [114], [115], [58], [20], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [94], [127], [128]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[535]
D1190		Osimertinib	C28H33N7O2	71496458	Moderate		Inter Info	[536]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[537], [538], [539], [540]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[537], [538], [539]
D1214		Palbociclib	C24H29N7O2	5330286	Moderate		Inter Info	[58], [20], [541]
D1221		Panobinostat	C21H23N3O2	6918837	Moderate		Inter Info	[542]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[543]
D1242		Pemigatinib	C24H27F2N5O4	86705695	Moderate		Inter Info	[20], [548]
D1253		Perampanel	C23H15N3O	9924495	Moderate		Inter Info	[20], [49]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[550]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[551]
D1330		Praziquantel	C19H24N2O2	4891	Moderate		Inter Info	[552], [58], [553], [554]
D1370		Quinestrol	C25H32O2	9046	Moderate		Inter Info	[25], [372], [26], [373], [27], [29], [374], [375], [376], [377], [30], [31], [378], [32], [379], [34], [380], [35], [38], [381], [382], [383], [40], [42], [43], [384], [44], [385], [386], [387], [388], [45], [389], [390], [391], [392], [393], [56], [394], [395], [396], [397], [398], [399], [57], [400], [401]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[409], [412], [356]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[409], [410], [411], [136], [412], [413], [414], [356]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[58], [457], [20], [558]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[58], [559]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Moderate		Inter Info	[560]
D1423		Rolapitant	C25H26F6N2O2	10311306	Moderate		Inter Info	[561]
D1434		Ruxolitinib	C17H18N6	25126798	Moderate		Inter Info	[562]
D1444		Saquinavir	C38H50N6O5	441243	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D1449		Saxagliptin	C18H25N3O2	11243969	Moderate		Inter Info	[563]
D1466		Silodosin	C25H32F3N3O4	5312125	Moderate		Inter Info	[58], [20], [564]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[565]
D1496		Sonidegib	C26H26F3N3O3	24775005	Moderate		Inter Info	[566]
D1502		St. John's Wort	NA	NA	Moderate		Inter Info	[409], [410], [411], [136], [412], [413], [414], [356]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[58], [20], [567]
D1524		Suvorexant	C23H23ClN6O2	24965990	Moderate		Inter Info	[568]
D1536		Tasimelteon	C15H19NO2	10220503	Moderate		Inter Info	[569]
D1538		Tazemetostat	C34H44N4O4	66558664	Moderate		Inter Info	[570]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[433], [434]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[571], [572]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[58], [20], [573]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Moderate		Inter Info	[61], [20], [575], [576], [577]
D1600		Tofacitinib	C16H20N6O	9926791	Moderate		Inter Info	[58], [578]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[20], [579]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[581]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[582]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[584]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Moderate		Inter Info	[585]
D1718		Zanubrutinib	C27H29N5O3	135565884	Moderate		Inter Info	[586]
D0646		Fentanyl	C22H28N2O	3345	Moderate		Inter Info	[113], [114], [115], [58], [20], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [94], [127], [128]
D0713		Gefitinib	C22H24ClFN4O3	123631	Moderate		Inter Info	[370], [587]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[588], [61], [58], [20], [589], [590]
D0845		Irinotecan	C33H38N4O6	60838	Moderate		Inter Info	[591], [592], [593], [594], [595], [596], [597], [598], [599], [600], [601], [602], [603], [604], [605]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Moderate		Inter Info	[592], [593], [598]
D0990		Medroxyprogesterone acetate	C24H34O4	6279	Moderate		Inter Info	[606], [607], [401]
D0993		Megestrol acetate	C24H32O4	11683	Moderate		Inter Info	[27], [379], [395]
D1017		Methadone	C21H27NO	4095	Moderate		Inter Info	[113], [114], [115], [58], [20], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [94], [127], [128]
D1037		Methylergometrine	C20H25N3O2	8226	Moderate		Inter Info	[58], [20], [350]
D1043		Methysergide	C21H27N3O2	9681	Moderate		Inter Info	[58], [20], [350]
D1078		Mitotane	C14H10Cl4	4211	Moderate		Inter Info	[409], [410], [411], [136], [412], [413], [414], [356]
D1081		Modafinil	C15H15NO2S	4236	Moderate		Inter Info	[418], [419]
D1087		Montelukast	C35H36ClNO3S	5281040	Moderate		Inter Info	[614]
D1119		Nelfinavir	C32H45N3O4S	64143	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D1143		Nitisinone	C14H10F3NO5	115355	Moderate		Inter Info	[61], [58], [20]
D1203		Oxycodone	C18H21NO4	5284603	Moderate		Inter Info	[113], [114], [115], [58], [20], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [94], [127], [128]
D1226		Paricalcitol	C27H44O3	5281104	Moderate		Inter Info	[129], [130], [131], [132]
D1348		Progesterone	C21H30O2	5994	Moderate		Inter Info	[25], [372], [26], [373], [27], [29], [374], [375], [376], [377], [30], [31], [378], [32], [379], [34], [380], [35], [38], [381], [382], [383], [40], [42], [43], [384], [44], [385], [386], [387], [388], [45], [389], [390], [391], [392], [393], [56], [394], [395], [396], [397], [398], [399], [57], [400], [401]
D1349		Progesterone (topical)	C21H30O2	5994	Moderate		Inter Info	[27], [379], [395]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[617], [618], [413], [619], [620], [621]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[622], [623], [624]
D1399		Rifabutin	C46H62N4O11	135398743	Moderate		Inter Info	[409], [410], [411], [136], [412], [413], [414], [356]
D1465		Sildenafil	C22H30N6O4S	135398744	Moderate		Inter Info	[625], [626], [627], [628]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[58], [20], [629], [630]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[631]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[58], [20], [629], [630]
D1527		Tadalafil	C22H19N3O4	110635	Moderate		Inter Info	[20], [632], [633]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[634], [635], [636], [637]
D1592		Tipranavir	C31H33F3N2O5S	54682461	Moderate		Inter Info	[77], [78], [79], [61], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92]
D1612		Toremifene	C26H28ClNO	3005573	Moderate		Inter Info	[640], [58], [20], [635], [641]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[642]
D0178		Bexarotene	C24H28O2	82146	Minor		Inter Info	[637]
D0193		Bortezomib	C19H25BN4O4	387447	Minor		Inter Info	[20], [643], [644], [645], [646]
D0308		Cevimeline	C10H17NOS	83898	Minor		Inter Info	[647]
D0420		Dapsone (topical)	C12H12N2O2S	2955	Minor		Inter Info	[648], [508], [511]
D0515		Dolutegravir	C20H19F2N3O5	54726191	Minor		Inter Info	[649]
D0700		Fostemsavir	C25H26N7O8P	11319217	Minor		Inter Info	[650]
D0916		Levobupivacaine	C18H28N2O	92253	Minor		Inter Info	[651]
D1074		Mirabegron	C21H24N4O2S	9865528	Minor		Inter Info	[652]
D0927		Lidocaine	C14H22N2O	3676	Minor		Inter Info	[653], [654], [655], [656]
	Increased metabolism (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0688		Folic acid	C19H19N7O6	135398658	Moderate		Inter Info	[519], [520], [521]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 154
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0219		Buprenorphine	C29H41NO4	644073	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15], [16]
D0467		Dextropropoxyphene	C22H29NO2	10100	Major		Inter Info	[22], [23], [24]
D1485		Sodium oxybate	C4H7NaO3	23663870	Major		Inter Info	[70], [71]
D0035		Alfentanil	C21H32N6O3	51263	Moderate		Inter Info	[74], [75], [76]
D0045		Alprazolam	C17H13ClN4	2118	Moderate		Inter Info	[74], [75], [76]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[74], [75], [76]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[93], [94]
D0135		Azatadine	C20H22N2	19861	Moderate		Inter Info	[74], [75], [76]
D0143		Baclofen	C10H12ClNO2	2284	Moderate		Inter Info	[74], [75], [76]
D0160		Benzatropine	C21H25NO	1201549	Moderate		Inter Info	[74], [75], [76]
D0205		Brimonidine (ophthalmic)	C11H10BrN5	2435	Moderate		Inter Info	[108], [20], [109]
D0206		Brimonidine (topical)	C11H10BrN5	2435	Moderate		Inter Info	[108], [20], [109]
D0214		Brompheniramine	C16H19BrN2	6834	Moderate		Inter Info	[74], [75], [76]
D0224		Butabarbital	C10H16N2O3	2479	Moderate		Inter Info	[74], [75], [76]
D0225		Butalbital	C11H16N2O3	2481	Moderate		Inter Info	[74], [75], [76]
D0259		Carbinoxamine	C16H19ClN2O	2564	Moderate		Inter Info	[74], [75], [76]
D0263		Carisoprodol	C12H24N2O4	2576	Moderate		Inter Info	[74], [75], [76]
D0305		Cetirizine	C21H25ClN2O3	2678	Moderate		Inter Info	[140], [141]
D0317		Chlordiazepoxide	C16H14ClN3O	2712	Moderate		Inter Info	[74], [75], [76]
D0322		Chlorphenesin	C9H11ClO3	7697	Moderate		Inter Info	[74], [75], [76]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[74], [75], [76]
D0327		Chlorzoxazone	C7H4ClNO2	2733	Moderate		Inter Info	[74], [75], [76]
D0356		Clobazam	C16H13ClN2O2	2789	Moderate		Inter Info	[74], [75], [76]
D0363		Clonidine	C9H9Cl2N3	2803	Moderate		Inter Info	[74], [75], [76]
D0365		Clorazepic acid	C16H11ClN2O3	2809	Moderate		Inter Info	[74], [75], [76]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[74], [75], [76]
D0398		Cyclobenzaprine	C20H21N	2895	Moderate		Inter Info	[74], [75], [76]
D0403		Cyproheptadine	C21H21N	2913	Moderate		Inter Info	[74], [75], [76]
D0456		Dexbrompheniramine	C16H19BrN2	16960	Moderate		Inter Info	[74], [75], [76]
D0459		Dexmedetomidine	C13H16N2	5311068	Moderate		Inter Info	[74], [75], [76]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[74], [75], [76]
D0532		Doxylamine	C17H22N2O	3162	Moderate		Inter Info	[74], [75], [76]
D0533		Dronabinol	C21H30O2	16078	Moderate		Inter Info	[74], [75], [76]
D0535		Droperidol	C22H22FN3O2	3168	Moderate		Inter Info	[74], [75], [76]
D0575		Entacapone	C14H15N3O5	5281081	Moderate		Inter Info	[74], [75], [76]
D0617		Ethanol	C2H6O	702	Moderate		Inter Info	[403], [404], [405], [20], [49]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[74], [75], [76]
D0071		Amobarbital	C11H18N2O3	2164	Moderate		Inter Info	[74], [75], [76]
D0098		Apraclonidine	C9H10Cl2N4	2216	Moderate		Inter Info	[108], [20], [109]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[74], [75], [76]
D0201		Brexanolone	C21H34O2	92786	Moderate		Inter Info	[437]
D0202		Brexpiprazole	C25H27N3O2S	11978813	Moderate		Inter Info	[74], [75], [76]
D0208		Brivaracetam	C11H20N2O2	9837243	Moderate		Inter Info	[74], [75], [76]
D0212		Bromocriptine	C32H40BrN5O5	31101	Moderate		Inter Info	[74], [75], [76]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[74], [75], [76]
D0311		Chloral hydrate	C2H3Cl3O2	2707	Moderate		Inter Info	[74], [75], [76]
D0318		Chlormezanone	C11H12ClNO3S	2717	Moderate		Inter Info	[74], [75], [76]
D0323		Chlorpheniramine	C16H19ClN2	2725	Moderate		Inter Info	[74], [75], [76]
D0359		Clofedanol	C17H20ClNO	2795	Moderate		Inter Info	[74], [75], [76]
D0417		Dantrolene	C14H10N4O5	6914273	Moderate		Inter Info	[74], [75], [76]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[74], [75], [76]
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[74], [75], [76]
D0470		Dezocine	C16H23NO	3033053	Moderate		Inter Info	[74], [75], [76]
D0471		Diamorphine	C21H23NO5	5462328	Moderate		Inter Info	[74], [75], [76]
D0493		Dihydrocodeine	C18H23NO3	5284543	Moderate		Inter Info	[74], [75], [76]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[74], [75], [76]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[74], [75], [76]
D0600		Esketamine	C13H16ClNO	182137	Moderate		Inter Info	[58], [486]
D0601		Eslicarbazepine	C15H14N2O2	9881504	Moderate		Inter Info	[74], [75], [76]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[74], [75], [76]
D0662		Flavoxate	C24H25NO4	3354	Moderate		Inter Info	[74], [75], [76]
D0665		Flibanserin	C20H21F3N4O	6918248	Moderate		Inter Info	[491]
D0791		Iloperidone	C24H27FN2O4	71360	Moderate		Inter Info	[74], [75], [76]
D0853		Isocarboxazid	C12H13N3O2	3759	Moderate		Inter Info	[74], [75], [76]
D0878		Kava	C14H16O3	5281052	Moderate		Inter Info	[74], [75], [76]
D0879		Ketamine	C13H16ClNO	3821	Moderate		Inter Info	[74], [75], [76]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[516]
D0917		Levocetirizine	C21H25ClN2O3	1549000	Moderate		Inter Info	[140], [141]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[74], [75], [76]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[74], [75], [76]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[74], [75], [76]
D1006		Mepyramine	C17H23N3O	4992	Moderate		Inter Info	[74], [75], [76]
D1046		Metoclopramide	C14H22ClN3O2	4168	Moderate		Inter Info	[74], [75], [76]
D1084		Molindone	C16H24N2O2	23897	Moderate		Inter Info	[74], [75], [76]
D1117		Nefazodone	C25H32ClN5O2	4449	Moderate		Inter Info	[74], [75], [76]
D1182		Opicapone	C15H10Cl2N4O6	135565903	Moderate		Inter Info	[74], [75], [76]
D1183		Opium	NA	NA	Moderate		Inter Info	[74], [75], [76]
D1188		Orphenadrine	C18H23NO	4601	Moderate		Inter Info	[74], [75], [76]
D1208		Oxymorphone	C17H19NO4	5284604	Moderate		Inter Info	[74], [75], [76]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[74], [75], [76]
D1224		Paraldehyde	C6H12O3	31264	Moderate		Inter Info	[74], [75], [76]
D1252		Pentoxyverine	C20H31NO3	2562	Moderate		Inter Info	[74], [75], [76]
D1255		Pergolide	C19H26N2S	47811	Moderate		Inter Info	[74], [75], [76]
D1292		Pimozide	C28H29F2N3O	16362	Moderate		Inter Info	[74], [75], [76]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[74], [75], [76]
D1367		Quazepam	C17H11ClF4N2S	4999	Moderate		Inter Info	[74], [75], [76]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[74], [75], [76]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[74], [75], [76]
D1385		Rasagiline	C12H13N	3052776	Moderate		Inter Info	[74], [75], [76]
D1431		Rotigotine	C19H25NOS	59227	Moderate		Inter Info	[74], [75], [76]
D1433		Rufinamide	C10H8F2N4O	129228	Moderate		Inter Info	[74], [75], [76]
D1464		Sibutramine	C17H26ClN	5210	Moderate		Inter Info	[74], [75], [76]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[74], [75], [76]
D1535		Tapentadol	C14H23NO	9838022	Moderate		Inter Info	[74], [75], [76]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[74], [75], [76]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[574]
D1576		Thiothixene	C23H29N3O2S2	941651	Moderate		Inter Info	[74], [75], [76]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[74], [75], [76]
D1675		Valerian	NA	NA	Moderate		Inter Info	[74], [75], [76]
D1694		Vigabatrin	C6H11NO2	5665	Moderate		Inter Info	[74], [75], [76]
D1716		Zaleplon	C17H15N5O	5719	Moderate		Inter Info	[74], [75], [76]
D1719		Ziconotide	C102H172N36O32S7	16135415	Moderate		Inter Info	[74], [75], [76]
D0679		Flurazepam	C21H23ClFN3O	3393	Moderate		Inter Info	[74], [75], [76]
D0748		Halazepam	C17H12ClF3N2O	31640	Moderate		Inter Info	[74], [75], [76]
D0750		Haloperidol	C21H23ClFNO2	3559	Moderate		Inter Info	[74], [75], [76]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[74], [75], [76]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[74], [75], [76]
D0923		Levorphanol	C17H23NO	5359272	Moderate		Inter Info	[74], [75], [76]
D0957		Loxapine	C18H18ClN3O	3964	Moderate		Inter Info	[74], [75], [76]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[74], [75], [76]
D1001		Meperidine	C15H21NO2	4058	Moderate		Inter Info	[608], [609], [610], [611], [612]
D1005		Meprobamate	C9H18N2O4	4064	Moderate		Inter Info	[74], [75], [76]
D1010		Mesoridazine	C21H26N2OS2	4078	Moderate		Inter Info	[74], [75], [76]
D1014		Metaxalone	C12H15NO3	15459	Moderate		Inter Info	[74], [75], [76]
D1023		Methocarbamol	C11H15NO5	4107	Moderate		Inter Info	[74], [75], [76]
D1053		Metyrosine	C10H13NO3	441350	Moderate		Inter Info	[74], [75], [76]
D1060		Midazolam	C18H13ClFN3	4192	Moderate		Inter Info	[74], [75], [76]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[74], [75], [76]
D1089		Morphine	C17H19NO3	5288826	Moderate		Inter Info	[74], [75], [76]
D1090		Morphine (liposomal)	C17H19NO3	5288826	Moderate		Inter Info	[74], [75], [76]
D1096		Nabilone	C24H36O3	5284592	Moderate		Inter Info	[74], [75], [76]
D1100		Nalbuphine	C21H27NO4	5311304	Moderate		Inter Info	[74], [75], [76]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[74], [75], [76]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[74], [75], [76]
D1172		Olopatadine (nasal)	C21H23NO3	5281071	Moderate		Inter Info	[403], [616], [49]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[74], [75], [76]
D1247		Pentazocine	C19H27NO	441278	Moderate		Inter Info	[74], [75], [76]
D1248		Pentobarbital	C11H18N2O3	4737	Moderate		Inter Info	[74], [75], [76]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[74], [75], [76]
D1263		Phenelzine	C8H12N2	3675	Moderate		Inter Info	[74], [75], [76]
D1325		Pramipexole	C10H17N3S	119570	Moderate		Inter Info	[74], [75], [76]
D1335		Pregabalin	C8H17NO2	5486971	Moderate		Inter Info	[74], [75], [76]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[74], [75], [76]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[74], [75], [76]
D1355		Propiomazine	C20H24N2OS	4940	Moderate		Inter Info	[74], [75], [76]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[74], [75], [76]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[74], [75], [76]
D1427		Ropinirole	C16H24N2O	5095	Moderate		Inter Info	[74], [75], [76]
D1453		Secobarbital	C12H18N2O3	5193	Moderate		Inter Info	[74], [75], [76]
D1512		Sufentanil	C22H30N2O2S	41693	Moderate		Inter Info	[74], [75], [76]
D1547		Temazepam	C16H13ClN2O2	5391	Moderate		Inter Info	[74], [75], [76]
D1573		Thiopental	C11H18N2O2S	3000715	Moderate		Inter Info	[74], [75], [76]
D1574		Thioridazine	C21H26N2S2	5452	Moderate		Inter Info	[74], [75], [76]
D1604		Tolcapone	C14H11NO5	4659569	Moderate		Inter Info	[74], [75], [76]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[74], [75], [76]
D1620		Tranylcypromine	C9H11N	19493	Moderate		Inter Info	[74], [75], [76]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[74], [75], [76]
D1632		Triazolam	C17H12Cl2N4	5556	Moderate		Inter Info	[74], [75], [76]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[74], [75], [76]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[74], [75], [76]
D1644		Trimethobenzamide	C21H28N2O5	5577	Moderate		Inter Info	[74], [75], [76]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[74], [75], [76]
D1649		Tripelennamine	C16H21N3	5587	Moderate		Inter Info	[74], [75], [76]
D1650		Triprolidine	C19H22N2	5282443	Moderate		Inter Info	[74], [75], [76]
	Additive immunosuppressive effects					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[20], [21]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[73]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[532]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[534]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[583]
	Additive myelosuppressive effects					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[58], [59], [60]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[58], [20], [493], [494]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[58], [20], [493], [494]
	Increased risk of hepatotoxicity					Drug Num: 24
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[61], [62], [63]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[66]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[68]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[69]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[61], [62], [63]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[97], [98], [99], [58], [20], [100], [101], [102], [103], [104], [105], [106], [107]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[145]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[367], [368]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[58], [20], [369]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[97], [98], [99], [58], [20], [100], [101], [102], [103], [104], [105], [106], [107]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[430]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[436]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[97], [98], [99], [58], [20], [100], [101], [102], [103], [104], [105], [106], [107]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[20], [442]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[505]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[544], [545], [546], [547]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[58], [20], [555], [556], [557]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[20], [580]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[544], [545], [546], [547]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[544], [545], [546], [547]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[20], [613]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[615]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[97], [98], [99], [58], [20], [100], [101], [102], [103], [104], [105], [106], [107]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[638], [639]
	Increased risk of hyponatremia					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0449		Desmopressin	C46H64N14O12S2	5311065	Moderate		Inter Info	[58], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285], [286], [287], [288], [289], [290], [291], [292], [293], [294], [295], [296], [297], [298], [299], [300], [301], [302], [303], [304], [20], [305], [306], [307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [61], [342], [343], [344], [345], [346]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[58], [169], [170], [171], [172], [173], [174], [175], [176], [177], [178], [179], [180], [181], [182], [183], [184], [185], [186], [187], [188], [189], [190], [191], [192], [193], [194], [195], [196], [197], [198], [199], [200], [201], [202], [203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260], [261], [262], [263], [264], [265], [266], [267], [268], [269], [270], [271], [272], [273], [274], [275], [276], [277], [278], [279], [280], [281], [282], [283], [284], [285], [286], [287], [288], [289], [290], [291], [292], [293], [294], [295], [296], [297], [298], [299], [300], [301], [302], [303], [304], [20], [305], [306], [307], [308], [309], [310], [311], [312], [313], [314], [315], [316], [317], [318], [319], [320], [321], [322], [323], [324], [325], [326], [327], [328], [329], [330], [331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [61], [342], [343], [344], [345], [346]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antiepileptic agents					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[58], [20], [142], [143], [144]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D0451		Desvenlafaxine	C16H25NO2	125017	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[58], [20], [142], [143], [144]
D1832		Levoleucovorin	C20H23N7O7	135398559	Moderate		Inter Info	[519], [520], [521]
D1833		Levomefolic acid	C20H25N7O6	135398561	Moderate		Inter Info	[519], [520], [521]
D1834		Levomefolic acid (calcium)	C20H25N7O6	135398561	Moderate		Inter Info	[519], [520], [521]
D0920		Levomilnacipran	C15H22N2O	6917779	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D1066		Milnacipran	C15H22N2O	65833	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D1243		Pemoline	C9H8N2O2	4723	Moderate		Inter Info	[58], [20], [549]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D1830		Leucovorin	C20H23N7O7	135403648	Moderate		Inter Info	[519], [520], [521]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[351], [352], [353], [48], [354], [355], [356], [19], [20], [357], [358], [359], [360], [361], [362], [363], [364], [365], [366], [51]
	Antagonize the effect of antihypertensive agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[496], [497], [498]

References
1	Sekar M, Mimpriss TJ "Buprenorphine, benzodiazepines and prolonged respiratory depression." Anaesthesia 42 (1987): 567-8. [PMID: 3592200]
2	Pirnay S, Borron SW, Giudicelli CP, Tourneau J, Baud FJ, Ricordel I "A critical review of the causes of death among post-morten toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths." Addiction 99 (2004): 978-88. [PMID: 15265095]
3	Schuman-Olivier Z, Hoeppner BB, Weiss RD, Borodovsky J, Shaffer HJ, Albanese MJ "Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes." Drug Alcohol Depend 132 (2013): 580-6. [PMID: 23688843]
4	Reynaud M, Petit G, Potard D, Courty P "Six deaths linked to concomitant use of buprenorphine and benzodiazepines." Addiction 93 (1998): 1385-92. [PMID: 9926544]
5	Kintz P "A new series of 13 buprenorphine-related deaths." Clin Biochem 35 (2002): 513-6. [PMID: 12493578]
6	Kilicarslan T, Sellers EM "Lack of interaction of buprenorphine with flunitrazepam metabolism." Am J Psychiatry 157 (2000): 1164-6. [PMID: 10873929]
7	Product Information. Suboxone (buprenorphine-naloxone). Reckitt and Colman Pharmaceuticals Inc, Richmond, VA.
8	Reynaud M, Tracqui A, Petit G, Potard D, Courty P "Six deaths linked to misuse of buprenorphine-benzodiazepine combinations." Am J Psychiatry 155 (1998): 448-9. [PMID: 9501765]
9	US Food and Drug Administration "FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines requires its strongest warning.".
10	Hakkinen M, Launiainen T, Vuori E, Ojanpera I "Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning." Eur J Clin Pharmacol 68 (2012): 301-9. [PMID: 21927835]
11	Gueye PN, Borron SW, Risede P, et al "Buprenorphine and midazolalm act in combination to depress respiration in rats." Toxicol Sci 65 (2002): 107-14. [PMID: 11752690]
12	Tracqui A, Kintz P, Ludes B "Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities." J Anal Toxicol 22 (1998): 430-4. [PMID: 9788517]
13	Martin HA "The possible consequences of combining lorazepam and buprenorphine/naloxone: a case review." J Emerg Nurs 37 (2011): 200-2. [PMID: 21397143]
14	Center for Substance Abuse Treatment.?Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004. [PMID: 22514846]
15	Ferrant O, Papin F, Clin B, et al "Fatal poisoning due to snorting buprenorphine and alcohol consumption." Forensic Sci Int 204 (2011): e8-11. [PMID: 20554411]
16	Kintz P "Deaths involving buprenorphine: a compendium of French cases." Forensic Sci Int 121 (2001): 65-9. [PMID: 11516889]
17	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
18	Priskorn M, Larsen F, Segonzac A, Moulin M "Pharmacokinetic interaction study of citalopram and cimetidine in healhy subjects." Eur J Clin Pharmacol 52 (1997): 241-2. [PMID: 9218934]
19	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
20	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
21	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
22	Abernethy DR, Greenblatt DJ, Morse DS, Shader RI "Interaction of propoxyphene with diazepam, alprazolam and lorazepam." Br J Clin Pharmacol 19 (1985): 51-7. [PMID: 2858217]
23	Peterson GR, Covault HP, Hostetler RM "Acute inhibition of microsomal drug metabolism by propoxphene in narcotic tolerant/dependent mice." Life Sci 22 (1978): 2087-96. [PMID: 566834]
24	Hansen BS, Dam M, Brandt J, et al "Influence of dextropropoxyphene on steady state serum levels and protein binding of three anti-epileptic drugs in man." Acta Neurol Scand 61 (1980): 357-67. [PMID: 6998251]
25	Baciewicz AM "Oral contraceptive drug interactions." Ther Drug Monit 7 (1985): 26-35. [PMID: 2859674]
26	Back DJ, Bates M, Bowden A, et al "The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy." Contraception 22 (1980): 495-503. [PMID: 7471739]
27	Back DJ, Breckenridge AM, Crawford FE, MacIver M, Orne ML, Rowe PH "Interindividual variation and drug interactions with hormonal steroid contraceptives." Drugs 21 (1981): 46-61. [PMID: 7009137]
28	Back DJ, Grimmer SF, Orme ML, Proudlove D, Mann RD, Breckenridge AM "Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anticonvulsants and antibiotics." Br J Clin Pharmacol 25 (1988): 527-32. [PMID: 3408633]
29	Back DJ, Orme ML "Pharmacokinetic drug interactions with oral contraceptives." Clin Pharmacokinet 18 (1990): 472-84. [PMID: 2191822]
30	Coulam CB, Annegers JF "Do anticonvulsants reduce the efficacy of oral contraceptives?" Epilepsia 20 (1979): 519-26. [PMID: 477641]
31	Crawford P, Chadwick DJ, Martin C, et al "The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids." Br J Clin Pharmacol 30 (1990): 892-6. [PMID: 2126946]
32	D'Arcy PF "Drug interactions with oral contraceptives." Drug Intell Clin Pharm 20 (1986): 353-62. [PMID: 3519141]
33	Diamond MP, Greene JW, Thompson JM, VanHooydonk JE, Wentz AC "Interaction of anticonvulsants and oral contraceptives in epileptic adolescents." Contraception 31 (1985): 623-32. [PMID: 4042660]
34	D'Arcy PF. Drug interactions with oral contraceptives. Drug Intell Clin Pharm. 1986;20(5):353-362. [PMID: 3519141]
35	Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception.".
36	Fattore C, Cipolla G, Gatti G, Limido GL, Sturm Y, Bernasconi C, Perucca E "Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbazepine in healthy women." Epilepsia 40 (1999): 783-7. [PMID: 10368079]
37	FFPRHC Guidance (April 2005). Drug interactions with hormonal contraception. J Fam Plann Reprod Health Care 31 (2005): 139-51. [PMID: 15921558]
38	Furlan AJ, Rothner AD "Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
39	Haukkamaa M "Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment." Contraception 33 (1986): 559-65. [PMID: 3095023]
40	Janz D, Schmidt D "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
41	Kenyon IE "Unplanned pregnancy in an epileptic. (Letter to the editor)." Br Med J 1 (1972): 686. [PMID: 5015305]
42	Klosterskov Jensen P, Saano V, Haring P, Svenstrup B, Menge GP "Possible interaction between oxcarbazepine and an oral contraceptive." Epilepsia 33 (1992): 1149-52. [PMID: 1464278]
43	Laengner H, Detering K "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 2 (1974): 600. [PMID: 4140317]
44	Mattson RH, Cramer JA, Darney PD, Naftolin F "Use of oral contraceptives by women with epilepsy." JAMA 256 (1986): 238-40. [PMID: 3723710]
45	Notelovitz M, Tjapkes J, Ware M "Interaction between estrogen and dilantin in a menopausal woman." N Engl J Med 304 (1981): 788-9. [PMID: 6258075]
46	O'Brien MD, Guillebaud J "Contraception for women with epilepsy." Epilepsia 47 (2006): 1419-22. [PMID: 16981856]
47	Odlind V, Olsson SE "Enhanced metabolism of levonorgestrel during phenytoin treatment in a woman with norplant implants." Contraception 33 (1986): 257-61. [PMID: 3087695]
48	Product Information. Aptiom (eslicarbazepine). Sunovion Pharmaceuticals Inc, Marlborough, MA.
49	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
50	Product Information. Norplant System (levonorgestrel) Wyeth-Ayerst Laboratories, Philadelphia, PA.
51	Product Information. Trileptal (oxcarbazepine) Novartis Pharmaceuticals, East Hanover, NJ.
52	Rapport DJ, Calabrese JR "Interactions between carbamazepine and birth control pills." Psychosomatics 30 (1989): 462-4. [PMID: 2798744]
53	Saano V, Glue P, Banfield CR "Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive." Clin Pharmacol Ther 58 (1995): 523-31. [PMID: 7586946]
54	Schindlbeck C, Janni W, Friese K "Failure of Implanon contraception in a patient taking carbamazepin for epilepsia." Arch Gynecol Obstet 273 (2006): 255-6. [PMID: 16208481]
55	Shane-McWorter L, Cerveny JD, MacFarlane LL, Osborn C "Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy." Pharmacotherapy 18 (1998): 1360-4. [PMID: 9855340]
56	Szoka PR, Edgren RA "Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database." Fertil Steril 49 (1988): s31-8. [PMID: 3282933]
57	Wilbur K, Ensom MHH "Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants." Clin Pharmacokinet 38 (2000): 355-65. [PMID: 10803456]
58	Cerner Multum, Inc. "Australian Product Information.".
59	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
60	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
61	Canadian Pharmacists Association.
62	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
63	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
64	Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
65	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
66	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
67	Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
68	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
69	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
70	Product Information. Xywav (calcium/magnesium/potass/sodium oxybates). Jazz Pharmaceuticals, Palo Alto, CA.
71	Product Information. Xyrem (sodium oxybate). Orphan Medical, Minnetonka, MN.
72	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
73	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
74	Divoll M, Greenblatt DJ, Lacasse Y, Shader RI "Benzodiazepine overdosage: plasma concentrations and clinical outcome." Psychopharmacology (Berl) 73 (1981): 381-3. [PMID: 6789361]
75	Grabowski BS, Cady WJ, Young WW, Emery JF "Effects of acute alcohol administration on propranolol absorption." Int J Clin Pharmacol Ther Toxicol 18 (1980): 317-9. [PMID: 7429677]
76	Product Information. Belsomra (suvorexant). Merck &amp Company Inc, Whitehouse Station, NJ.
77	Acosta EP, Henry K, Baken L, Page LM, Fletcher CV "Indinavir concentrations and antiviral effect." Pharmacotherapy 19 (1999): 708-12. [PMID: 10391416]
78	Barry M, Gibbons S, Back D, Mulcahy F "Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations." Clin Pharmacokinet 32 (1997): 194-209. [PMID: 9084959]
79	Brooks J, Daily J, Schwamm L "Protease inhibitors and anticonvulsants." AIDS Clin Care 9 (1997): 87,90. [PMID: 11364776]
80	Hugen PWH, Burger DM, Brinkman K, terHofstede HJM, Schuurman R, Koopmans PP, Hekster YA "Carbamazepine-indinavir interaction causes antiretroviral therapy failure." Ann Pharmacother 34 (2000): 465-70. [PMID: 10772431]
81	Liedtke MD, Lockhart SM, Rathbun RC "Anticonvulsant and antiretroviral interactions." Ann Pharmacother 38 (2004): 482-9. [PMID: 14970370]
82	Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
83	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
84	Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
85	Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
86	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
87	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
88	Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
89	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
90	Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
91	Sommadossi JP "HIV protease inhibitors: pharmacologic and metabolic distinctions." AIDS 13 (1999): s29-40. [PMID: 10546783]
92	Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
93	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
94	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
95	Product Information. Emend (aprepitant). Merck & Company Inc, West Point, PA.
96	Product Information. Emend for Injection (fosaprepitant). Merck & Company Inc, West Point, PA.
97	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
98	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
99	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
100	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
101	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
102	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
103	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
104	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
105	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
106	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
107	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
108	Product Information. Alphagan (brimonidine ophthalmic). Allergan Inc, Irvine, CA.
109	Product Information. Mirvaso (brimonidine topical). Galderma Laboratories Inc, Cranbury, NJ.
110	Kivisto KT, Lamberg TS, Neuvonen PJ "Interactions of buspirone with itraconazole and rifampicin: Effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone." Pharmacol Toxicol 84 (1999): 94-7. [PMID: 10068153]
111	Lamberg TS, Kivisto KT, Neuvonen PJ "Concentrations and effects of buspirone are considerably reduced by rifampicin." Br J Clin Pharmacol 45 (1998): 381-5. [PMID: 9578186]
112	Product Information. Buspar (buspirone). Bristol-Myers Squibb, Princeton, NJ.
113	Altice FL, Friedland GH, Cooney EL "Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone." AIDS 13 (1999): 957-62. [PMID: 10371177]
114	Bell J, Seres V, Bowron P, Lewis J, Batey R "The use of serum methadone levels in patients receiving methadone maintenance." Clin Pharmacol Ther 43 (1988): 623-9. [PMID: 3378383]
115	Bending MR, Skacel PO "Rifampicin and methadone withdrawal." Lancet 1 (1977): 1211. [PMID: 68314]
116	Finelli PF "Phenytoin and methadone tolerance." N Engl J Med 294 (1976): 227. [PMID: 1244546]
117	Holmes VF "Rifampin-induced methadone withdrawal in AIDS." J Clin Psychopharmacol 10 (1991): 443-4. [PMID: 2286719]
118	Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM "Rifampin-induced methadone withdrawal." N Engl J Med 294 (1976): 1104-6. [PMID: 1256526]
119	Liu S-J, Wang RI "Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome." Am J Psychiatry 141 (1984): 1287-8. [PMID: 6486271]
120	Otero MJ, Fuertes A, Sanchez R, Luna G "Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert." AIDS 13 (1999): 1004-5. [PMID: 10371190]
121	Pinzani V, Faucherre V, Peyriere H, Blayac JP "Methadone withdrawal symptoms with nevirapine and efavirenz." Ann Pharmacother 34 (2000): 405-7. [PMID: 10917395]
122	Product Information. Butorphanol Tartrate (butorphanol). Apotex Corporation, Weston, FL.
123	Product Information. Diskets (methadone). Cebert Pharmaceuticals Inc, Birmingham, AL.
124	Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
125	Product Information. Ionsys (fentanyl). Ortho McNeil Pharmaceutical, Raritan, NJ.
126	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
127	Raistrick D, Hay A, Wolff K "Methadone maintenance and tuberculosis treatment." BMJ 313 (1996): 925-6. [PMID: 8876100]
128	Tong TG, Pond SM, Kreek MJ, et al "Phenytoin-induced methadone withdrawal." Ann Intern Med 94 (1981): 349-51. [PMID: 7224382]
129	Product Information. Hectorol (doxercalciferol). Genzyme Corporation, Cambridge, MA.
130	Product Information. One-Alpha (alfacalcidol). Pharmel Inc, Montreal, IN.
131	Product Information. Rocaltrol (calcitriol). Roche Laboratories, Nutley, NJ.
132	Product Information. Zemplar (paricalcitol). Abbott Pharmaceutical, Abbott Park, IL.
133	Albani F, Theodore WH, Washington P, Devinsky O, Bromfield E, Porter RJ, Nice FJ "Effect of felbamate on plasma levels of carbamazepine and its metabolites." Epilepsia 32 (1991): 130-2. [PMID: 1985822]
134	Fuerst RH, Graves NM, Leppik IE, Brundage RC, Holmes GB, Remmel RP "Felbamate increases phenytoin but decreases carbamazepine concentrations." Epilepsia 29 (1988): 488-91. [PMID: 3391153]
135	Graves NM, Holmes GB, Fuerst RH, Leppik IE "Effect of felbamate on phenytoin and carbamazepine serum concentrations." Epilepsia 30 (1989): 225-9. [PMID: 2647472]
136	Product Information. Felbatol (felbamate). Wallace Laboratories, Cranbury, NJ.
137	Wagner ML, Graves NM, Marienau K, Holmes GB, Remmel RP, Leppik IE "Discontinuation of phenytoin and carbamazepine in patients receiving felbamate." Epilepsia 32 (1991): 398-406. [PMID: 1904346]
138	Wagner ML, Remmel RP, Graves NM, Leppik IE "Effect of felbamate on carbamazepine and its major metabolites." Clin Pharmacol Ther 53 (1993): 536-43. [PMID: 8491065]
139	Product Information. Cancidas (caspofungin) Merck & Co, Inc, West Point, PA.
140	Product Information. Zyrtec (cetirizine). Pfizer US Pharmaceuticals, New York, NY.
141	Product Information. Xyzal (levocetirizine). UCB Pharma Inc, Smyrna, GA.
142	Product Information. Aralen (chloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
143	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
144	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
145	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
146	Collet JP, Hulot JS, Pena A, et al. "Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study." Lancet 373 (2009): 309-17. [PMID: 19108880]
147	Frere C, Cuisset T, Morange PE, et al. "Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary Syndrome." Am J Cardiol 101 (2008): 1088-1093. [PMID: 18394438]
148	Gilard M, Arnaud B, Cornily JC, et al "Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study." J Am Coll Cardiol 51 (2008): 256-60. [PMID: 18206732]
149	Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J "Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin." J Thromb Haemost 4 (2006): 2508-9. [PMID: 16898956]
150	Hulot JS, Bura A, Villard E, et al. "Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects." Blood (2006):. [PMID: 16772608]
151	Juurlink DN, Gomes T, Ko DT, et al "A population-based study of the drug interaction between proton pump inhibitors and clopidogrel." CMAJ 180 (2009): 713-8. [PMID: 19176635]
152	Lau WC, Gurbel PA "The drug-drug interaction between proton pump inhibitors and clopidogrel." CMAJ 180 (2009): 699-700. [PMID: 19332744]
153	Li XQ, Andersson TB, Ahlstrom M, Weidolf L "Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities." Drug Metab Dispos 32 (2004): 821-7. [PMID: 15258107]
154	Mega JL, Close SL, Wiviott SD, et al. "Cytochrome p-450 polymorphisms and response to clopidogrel." N Engl J Med 360 (2009): 354-62. [PMID: 19106084]
155	Moayyedi P, Sadowski DC "Proton pump inhibitors and clopidogrel -- hazardous drug interaction or hazardous interpretation of data?" Can J Gastroenterol 23 (2009): 251-2. [PMID: 19373416]
156	Ohyama K, Nakajima M, Suzuki M, Shimada N, Yamazaki H, Yokoi T "Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: Prediction of in vivo drug interactions." Br J Clin Pharmacol 49 (2000): 244-53. [PMID: 10718780]
157	Pezalla E, Day D, Pulliadath I "Initial assessment of clinical impact of a drug interaction between clopidogrel and proton pump inhibitors." J Am Coll Cardiol 52 (2008): 1038-9. [PMID: 18786491]
158	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
159	Product Information. Kapidex (dexlansoprazole). Takeda Pharmaceuticals America, Lincolnshire, IL.
160	Product Information. Plavix (clopidogrel). Bristol-Myers Squibb, Princeton, NJ.
161	Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B "Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel." Am Heart J 157 (2009): 148.e1-5. [PMID: 19081411]
162	Simon T, Verstuyft C, Mary-Krause M, et al "Genetic determinants of response to clopidogrel and cardiovascular events." N Engl J Med 360 (2009): 363-75. [PMID: 19106083]
163	Small DS, Farid NA, Payne CD, et al. "Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel." J Clin Pharmacol 48 (2008): 475-84. [PMID: 18303127]
164	Varenhorst C, Janes S, Erlinge D, et al "Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease." Eur Heart J 30 (2009): 1744-52. [PMID: 19429918]
165	Product Information. Welchol (colesevelam) Daiichi Sankyo, Inc., Parsippany, NJ.
166	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
167	Borin MT, Chambers JH, Carel BJ, Gagnon S, Freimuth WW "Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate." Clin Pharmacol Ther 61 (1997): 544-53. [PMID: 9164416]
168	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
169	Vanhees SL, Paridaens R, Vansteenkiste JF "Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review." Ann Oncol 11 (2000): 1061-5. [PMID: 11038047]
170	Maramattom BV "Duloxetine-induced syndrome of inappropriate antidiuretic hormone secretion and seizures." Neurology 66 (2006): 773-4. [PMID: 16534127]
171	Kosmidis HV, Bouhoutsou DO, Varvoutsi MC, et al. "Vincristine overdose: experience with 3 patients." Pediatr Hematol Oncol 8 (1991): 171-8. [PMID: 1863543]
172	Miller MG "Tricyclics as a possible cause of hyponatremia in psychiatric patients." Am J Psychiatry 146 (1989): 807. [PMID: 2729439]
173	Kokko H, Hall PD, Afrin LB "Fentanyl-associated syndrome of inappropriate antidiuretic hormone secretion." Pharmacotherapy 22 (2002): 1188-92. [PMID: 12222557]
174	ten Holt WL, van Iperen CE, Schrijver G, Bartelink AK "Severe hyponatremia during therapy with fluoxetine." Arch Intern Med 156 (1996): 681-2. [PMID: 21216670]
175	Nielsen OA, Johannessen AC, Bardrum B "Oxcarbazepine-induced hyponatremia, a cross-sectional study." Epilepsy Res 2 (1988): 269-71. [PMID: 3197696]
176	Schattner A, Skurnik Y "Fluoxetine-induced SIADH." J Am Geriatr Soc 44 (1996): 1413. [PMID: 8909370]
177	Goldstein L, Barker M, Segall F, Asihene R, Balser S, Lautenbach D, Mccoy M "Seizure and transient SIADH associated with sertraline." Am J Psychiatry 153 (1996): 732. [PMID: 8615425]
178	el Weshi A, Thieblemont C, Cottin V, Barbet N, Catimel G "Cisplatin-induced hyponatremia and renal sodium wasting." Acta Oncol 34 (1995): 264-5. [PMID: 7718269]
179	Tanay A, Firemann Z, Yust I, Abramov AL "Chlorpropamide-induced syndrome of inappropriate antidiuretic hormone secretion." J Am Geriatr Soc 29 (1981): 334-6. [PMID: 7240625]
180	Lahr MB "Hyponatremia during carbamazepine therapy." Clin Pharmacol Ther 37 (1985): 693-6. [PMID: 4006369]
181	Catalano G, Kanfer SN, Catalano MC, Alberts VA "The role of sertraline in a patient with recurrent hyponatremia." Gen Hosp Psychiatry 18 (1996): 278-83. [PMID: 8832263]
182	Cohen BJ, Mahelsky M, Adler L "More cases of SIADH with fluoxetine." Am J Psychiatry 147 (1990): 948-9. [PMID: 2356883]
183	Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
184	Littlewood TJ, Smith AP "Syndrome of inappropriate antidiuretic hormone secretion due to treatment of lung cancer with cisplatin." Thorax 39 (1984): 636-7. [PMID: 6089367]
185	Jacob S, Spinler SA "Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults." Ann Pharmacother 40 (2006): 1618-22. [PMID: 16896026]
186	Kadowaki T, Hagura R, Kajinuma H, et al "Chlorpropamide-induced hyponatremia: incidence and risk factors." Diabetes Care 6 (1983): 468-71. [PMID: 6443808]
187	Laycock JF, Lewis AF "Potentiation of the response to vasopressin (pitressin) by treatment with a combination of chlorpropamide and chlorothiazide in Brattleboro rats with hereditary hypothalamic diabetes insipidus." Br J Pharmacol 59 (1977): 11-6. [PMID: 836992]
188	Ayonrinde OT, Reutens SG, Sanfilippo FM "Paroxetine-induced SIADH." Med J Aust 163 (1995): 390. [PMID: 7565274]
189	Hamburger S, Langley H, Bowers G "The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline or trifluoperazine administration." J Kans Med Soc 81 (1980): 469-70. [PMID: 7229499]
190	Petersson I, Nilsson G, Hansson B-G, Hedner T "Water intoxication associated with non-steroidal anti-inflammatory drug therapy." Acta Med Scand 221 (1987): 221-3. [PMID: 3591460]
191	Kagawa K, Fujitaka K, Isobe T, et al "Syndrome of inappropriate secretion of ADH (SIADH) following cisplatin administration in a pulmonary adenocarcinoma patient with a malignant pleural effusion." Intern Med 40 (2001): 1020-3. [PMID: 11688826]
192	Gandelman MS "Review of carbamazepine-induced hyponatremia." Prog Neuropsychopharmacol Biol Psychiatry 18 (1994): 211-33. [PMID: 8208974]
193	Ashton MG, Ball SG, Thomas TH, Lee MR "Water intoxication associated with carbamazepine tretment." Br Med J 1 (1977): 1134-5. [PMID: 861500]
194	McCarron M, Wright GD, Roberts SD "Water intoxication after low dose cyclophosphamide." BMJ 311 (1995): 292. [PMID: 7633237]
195	Garrett CA, Simpson TA "Syndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy." Ann Pharmacother 32 (1998): 1306-9. [PMID: 9876812]
196	Stephens WP, Coe JY, Baylis PH "Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine." Br Med J 1 (1978): 1445-7. [PMID: 647329]
197	Chua TP, Vong SK "Hyponatraemia associated with paroxetine." BMJ 306 (1993): 143. [PMID: 8435627]
198	Giles PD, Seem CC "Dothiepin and water handling." Lancet 2 (1985): 1013. [PMID: 2865482]
199	Luzecky MH, Burman KD, Schultz ER "The syndrome of inappropriate secretion of antidiuretic hormone associated with amitriptyline administration." South Med J 67 (1974): 495-7. [PMID: 4817485]
200	Pledger DR, Mathew H "Hyponatraemia and clomipramine therapy." Br J Psychiatry 154 (1989): 263-4. [PMID: 2775959]
201	Whittaker JA, Parry DH, Bunch C, Weatherall DJ "Coma associated with vincristine therapy." Br Med J 4 (1973): 335-7. [PMID: 4758426]
202	Kosten TR, Camp W "Inappropriate secretion of antidiuretic hormone in a patient receiving piperazine phenothiazines." Psychosomatics 21 (1980): 351,354-5. [PMID: 7384399]
203	Mitsch RA, Lee AK "Syndrome of inappropriate antidiuretic hormone with imipramine." Drug Intell Clin Pharm 20 (1986): 787-9. [PMID: 3769770]
204	Cheung NT, Coley S, Sheeran T, Situnayake RD "Syndrome of inappropriate secretion of antidiuretic hormone induced by diclofenac." BMJ 306 (1993): 186. [PMID: 8443484]
205	Rault RM "Case report: hyponatremia associated with nonsteroidal antiinflammatory drugs." Am J Med Sci 305 (1993): 318-20. [PMID: 8484392]
206	Belton K, Thomas SH "Drug-induced syndrome of inappropriate antidiuretic hormone secretion." Postgrad Med J 75 (1999): 509-10. [PMID: 10646042]
207	Cutting HO "Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy." Am J Med 51 (1971): 269-71. [PMID: 5095530]
208	Bavbek N, Kargili A, Akcay A, Kaya A "Recurrent hyponatremia associated with citalopram and mirtazapine." Am J Kidney Dis 48 (2006): e61-2. [PMID: 16997047]
209	Lichtigfeld FJ, Gillman MA "Dangerous synergism between sedatives and a hyponatraemic state." J R Soc Med 83 (1990): 185. [PMID: 2325062]
210	Product Information. Vasopressin (vasopressin). APP (Abraxis Pharmaceutical Products), Schaumberg, IL.
211	Blacksten JV, Birt JA "Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine." Ann Pharmacother 27 (1993): 723-4. [PMID: 8329791]
212	Llorente MD, Gorelick M, Silverman MA "Sertraline as the cause of inappropriate antidiuretic hormone secretion." J Clin Psychiatry 55 (1994): 543-4. [PMID: 7814351]
213	Munro AH, Crompton GK "Inappropriate antidiuretic hormone secretion in oat-cell carcinoma of bronchus. Aggravation of hyponatraemia by intravenous cyclophosphamide." Thorax 27 (1972): 640-2. [PMID: 4343447]
214	Gupta AK, Saravay SM "Venlafaxine-induced hyponatremia." J Clin Psychopharmacol 17 (1997): 223-5. [PMID: 9169969]
215	Kinzie BJ "Management of the syndrome of inappropriate secretion of antidiuretic hormone." Clin Pharm 6 (1987): 625-33. [PMID: 3121240]
216	Egger C, Muehlbacher M, Nickel M, Geretsegger C, Stuppaeck C "A case of recurrent hyponatremia induced by venlafaxine." J Clin Psychopharmacol 26 (2006): 439. [PMID: 16855472]
217	Schwab M, Roder F, Morike K, Thon KP, Klotz U "Drug-induced hyponatraemia in elderly patients." Br J Clin Pharmacol 48 (1999): 105-6. [PMID: 10417484]
218	Webberley MJ, Murray JA "Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin." Postgrad Med J 65 (1989): 950-2. [PMID: 2616440]
219	Staab JP, Yerkes SA, Cheney EM, Clayton AH "Transient SIADH associated with fluoxetine." Am J Psychiatry 147 (1990): 1569-70. [PMID: 2221175]
220	Girault C, Richard JC, Chevron V, Goulle JP, Droy JM, Bonmarchand G, Leroy J "Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with elevated serum fluoxetine." J Toxicol Clin Toxicol 35 (1997): 93-5. [PMID: 9022659]
221	Doshi D, Borison R "Association of transient SIADH with sertraline." Am J Psychiatry 151 (1994): 779-80. [PMID: 8166325]
222	Kimura T, Ota K, Shoju M et al "Chlorpropamide-induced ADH release, hyponatremia and central pontine myelinolysis in diabetes mellitus." Tohoku J Exp Med 177 (1995): 303-13. [PMID: 8928190]
223	Bradley ME, Foote EF, Lee EN, Merkle L "Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature." Pharmacotherapy 16 (1996): 680-3. [PMID: 8840376]
224	Matsumura M, Yamaguchi M, Sato T "Severe hyponatremia in a patient treated with levomepromazine and carbamazepine." Intern Med 40 (2001): 459. [PMID: 11393424]
225	Epstein S, Van Mieghem W, Simson E, Jackson WP "Chlorpropamide hyponatremia." N Engl J Med 286 (1972): 785. [PMID: 5025793]
226	Appel WC "Possible roles of normeperidine and hyponatremia in a postoperative death." Can Med Assoc J 137 (1987): 912-3. [PMID: 3676934]
227	Agrawal NK, Rastogi A, Goyal R, Singh SK "Sertraline-induced hyponatremia in the elderly." CJEM 9 (2007): 415. [PMID: 18072985]
228	Jayachandran NV, Chandrasekhara PK, Thomas J, Agrawal S, Narsimulu G "Cyclophosphamide-associated complications: we need to be aware of SIADH and central pontine myelinolysis." Rheumatology 48 (2009): 89-90. [PMID: 18988633]
229	Bouman WP, Johnson H, TrescoliSerrano C, Jones RG "Recurrent hyponatremia associated with sertraline and lofepramine." Am J Psychiatry 154 (1997): 580. [PMID: 9090354]
230	Pillans PI, Coulter DM "Fluoxetine and hyponatraemia - a potential hazard in the elderly." N Z Med J 107 (1994): 85-6. [PMID: 8202292]
231	Sloan RW, Kreider RM, Luderer JR "The effect of chlorpropamide hyponatremia on mental status in a nursing home population." J Fam Pract 16 (1983): 937-42. [PMID: 6842150]
232	Moses AM, Miller M "Drug-induced dilutional hyponatremia." N Engl J Med 291 (1974): 1234-9. [PMID: 4607502]
233	Tomiwa K, Mikawa H, Hazama F, Yazawa K, Hosoya R, Ohya T, Nishimura K "Syndrome of inappropriate secretion of antidiuretic hormone caused by vincristine therapy: a case report of the neuropathology." J Neurol 229 (1983): 267-72. [PMID: 6192229]
234	Robinson D, Brooks J, Mahler E, Sheikh JI "SIADH--compulsive drinking or SSRI influence?" Ann Pharmacother 30 (1996): 885. [PMID: 8826582]
235	Wilkinson TJ, Begg EJ, Winter AC, Sainsbury R "Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly people." Br J Clin Pharmacol 47 (1999): 211-7. [PMID: 10190657]
236	Dirks AC, van Hyfte DM "Recurrent hyponatremia after substitution of citalopram with duloxetine." J Clin Psychopharmacol 27 (2007): 313. [PMID: 17502788]
237	Izzedine H, Launay-Vacher V, Ciroldi M, Fardet L, Deray G "Fanconi and inappropriate secretion of antidiuretic hormone syndromes secondary to venlafaxine therapy." Nephron 92 (2002): 944-6. [PMID: 12399647]
238	Smith NJ, Espir ML, Baylis PH "Raised plasma arginine vasopressin concentration in carbamazepine-induced water intoxication." Br Med J 2 (1977): 804. [PMID: 912329]
239	Sarret D, Le Berre JP, Zemraoui N "Tramadol-induced hyponatremia." Am J Kidney Dis 52 (2008): 1026 author reply 1027. [PMID: 18971023]
240	Meynaar IA, Peeters AJ, Mulder AH, Ottervanger JP "Syndrome of inappropriate ADH secretion attributed to the serotonin re-uptake inhibitors, venlafaxine and paroxetine." Neth J Med 50 (1997): 243-5. [PMID: 9232089]
241	Instituto de Salud Pblica de Chile "Sistema de Consulta de Productos Registrados.".
242	Madhusoodanan S, Osnos R "Amitriptyline induced hyponatremia: a case report." Mt Sinai J Med 48 (1981): 431-3. [PMID: 6975430]
243	Degner D, Grohmann R, Kropp S, et al. "Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP." Pharmacopsychiatry 37 Suppl 1 (2004): S39-45. [PMID: 15052513]
244	Selective serotonin reuptake inhibitors and SIADH. Med J Aust 164 (1996): 562. [PMID: 8649298]
245	Orbo A, Simonsen E "Cisplatin-induced sodium and magnesium wastage." Eur J Cancer 28A (1992): 1294. [PMID: 1627398]
246	Johannessen AC, Nielsen OA "Hyponatremia induced by oxcarbazepine." Epilepsy Res 1 (1987): 155-6. [PMID: 3143548]
247	Kazal LA, Jr Hall DL, Miller LG, Noel ML "Fluoxetine-induced SIADH: a geriatric occurrence?" J Fam Pract 36 (1993): 341-3. [PMID: 8454983]
248	Goddard C, Paton C "Hyponatraemia associated with paroxetine." BMJ 305 (1992): 1332. [PMID: 1483080]
249	Fort S, Bannister P, Manning A, Bolton R, Losowsky MS "Inappropriate antidiuretic hormone secretion associated with dothiepin." Lancet 2 (1985): 551. [PMID: 2863561]
250	Product Information. DDAVP (desmopressin). Rhone-Poulenc Rorer, Collegeville, PA.
251	Vishwanath BM, Navalgund AA, Cusano W, Navalgund KA "Fluoxetine as a cause of SIADH." Am J Psychiatry 148 (1991): 542-3. [PMID: 2006703]
252	Inappropriate antidiuretic hormone secretion. West J Med 122 (1975): 145-9. [PMID: 1114800]
253	Palmer BF, Gates JR, Lader M "Causes and management of hyponatremia." Ann Pharmacother 37 (2003): 1694-702. [PMID: 14565794]
254	Famularo G, Gasbarrone L, De Virgilio A, Minisola G "Mirtazapine-associated hyponatremia in an elderly patient." Ann Pharmacother 43 (2009): 1144-5. [PMID: 19435965]
255	O'Sullivan D, Oyebode F "Hyponatraemia and lofepramine." Br J Psychiatry 150 (1987): 720-1. [PMID: 3651721]
256	Liu BA, Mittmann N, Knowles SR, Shear NH "Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotoni reuptake inhibitors: a review of spontaneous reports [publishe erratum appears in Can Med Assoc J 1996 Oct 15 155(8):1043." CMAJ 155 (1996): 519-27. [PMID: 8804257]
257	Abbott R "Hyponatremia due to antidepressant medications." Ann Emerg Med 12 (1983): 708-10. [PMID: 6638632]
258	Perucca E, Garratt A, Hebdige S, Richens A "Water intoxication in epileptic patients receiving carbamazepine." J Neural Neurosurg Psychiatry 41 (1978): 713-8. [PMID: 681958]
259	Jacob S, Spinler SA. Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother. 2006;40(9):1618-1622. [PMID: 16896026]
260	Safdieh JE, Rudominer R "A case of hyponatremia induced by duloxetine." J Clin Psychopharmacol 26 (2006): 675-676. [PMID: 17110834]
261	Culine S, Ghosn M, Droz JP "Inappropriate antidiuretic hormone secretion induced by ifosfamide." Eur J Cancer 26 (1990): 922. [PMID: 2145942]
262	Harris RC "Cyclooxygenase-2 inhibition and renal physiology." Am J Cardiol 89(6 Suppl 1) (2002): 10-7. [PMID: 11909556]
263	Product Information. Vasostrict (vasopressin). Par Pharmaceutical Inc, Chestnut Ridge, NY.
264	DeFronzo RA, Braine H, Colvin M, Davis PJ "Water intoxication in man after cyclophosphamide therapy: time course and relation to drug activation." Ann Intern Med 78 (1973): 861-9. [PMID: 4713567]
265	Lazarevic V, Hagg E, Wahlin A "Hiccups and severe hyponatremia associated with high-dose cyclophosphamide in conditioning regimen for allogeneic stem cell transplantation." Am J Hematol 82 (2007): 88. [PMID: 16917917]
266	Levsky ME, Schwartz JB "Sertraline-induced hyponatremia in an older patient." J Am Geriat Soc 46 (1998): 1582-3. [PMID: 9848826]
267	Moses AM, Howanitz J, Miller M "Diuretic action of three sulfonylurea drugs." Ann Intern Med 78 (1973): 541-4. [PMID: 4632790]
268	van Campen JP, Voets AJ "SIADH caused by paroxetine." Ann Pharmacother 30 (1996): 1499. [PMID: 8968470]
269	Fonseca VA, Deb M, Gokani SS, Bhandarkar SD "Chlorpropamide induced syndrome of inappropriate antidiuretic hormone secretion." J Postgrad Med 26 (1980): 127-30. [PMID: 7218172]
270	Weir MR "Renal effects of nonselective NSAIDs and coxibs." Cleve Clin J Med 69(Suppl 1) (2002): SI53-8. [PMID: 12086295]
271	Davis FB, Davis PJ "Water metabolism in diabetes mellitus." Am J Med 70 (1981): 210-4. [PMID: 7457488]
272	Bjorck E, Samuelsson J "Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) after treatment with cyclophosphamide, alpha-interferon and betamethasone in a patient with multiple myeloma." Eur J Haematol 56 (1996): 323-5. [PMID: 8641409]
273	Cilli AS, Algun E "Oxcarbazepine-induced syndrome of inappropriate secretion of antidiuretic hormone." J Clin Psychiatry 63 (2002): 742. [PMID: 12197457]
274	Oldham RK, Pomeroy TC "Vincristine-induced syndrome of inappropriate secretion of antidiuretic hormone." South Med J 65 (1972): 1010-2. [PMID: 4557951]
275	Garson M "Syndrome of dilutional hyponatraemia secondary to tricyclic antidepressant." Practitioner 222 (1979): 411-2. [PMID: 450841]
276	Ortenzi A, Paggi A, Foschi N, Sabbatini D, Pistoli E "Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy." Funct Neurol 23 (2008): 97-100. [PMID: 18671911]
277	Nicholson RG, Feldman W "Hyponatremia in association with vincristine therapy." Can Med Assoc J 106 (1972): 356-7. [PMID: 4501374]
278	John L, Perreault MM, Tao T, Blew PG "Serotonin syndrome associated with nefazodone and paroxetine." Ann Emerg Med 29 (1997): 287-9. [PMID: 9018197]
279	Crews JR, Potts NL, Schreiber J, Lipper S "Hyponatremia in a patient treated with sertraline." Am J Psychiatry 150 (1993): 1564. [PMID: 8379571]
280	Ryan M, Adams AG, Larive LL "Hyponatremia and leukopenia associated with oxcarbazepine following carbamazepine therapy." Am J Health Syst Pharm 58 (2001): 1637-9. [PMID: 11556658]
281	Kalff R, Houtkooper MA, Meyer JW, et al "Carbamazepine and serum sodium levels." Epilepsia 24 (1984): 390-7. [PMID: 6327253]
282	Levin L, Sealy R, Barron J "Syndrome of inappropriate antidiuretic hormone secretion following cis-dichlorodiammineplatinum II in a patient with malignant thymoma." Cancer 50 (1982): 2279-82. [PMID: 6890402]
283	Hamed M, Mitchell H, Clow DJ "Hyponatraemic convulsion associated with desmopressin and imipramine treatment." BMJ 306 (1993): 1169. [PMID: 8499820]
284	Paliwal V, Garg RK, Kar AM, Singh MK "Oxcarbazepine induced hyponatremic coma." Neurol India 54 (2006): 214-5. [PMID: 16804276]
285	Kruger S, Lindstaedt M "Duloxetine and hyponatremia: a report of 5 cases." J Clin Psychopharmacol 27 (2007): 101-104. [PMID: 17224730]
286	Dong X, Leppik IE, White J, Rarick J "Hyponatremia from oxcarbazepine and carbamazepine." Neurology 65 (2005): 1976-8. [PMID: 16380624]
287	Cantwell BM, Idle M, Millward MJ, Hall G, Lind MJ "Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion." Ann Oncol 1 (1990): 232. [PMID: 2261371]
288	Bourgeois JA "Reversible hyponatremia and venlafaxine." Psychosomatics 46 (2005): 495-6. [PMID: 16145194]
289	Purcell P, Valmana A "Toxic epidermal necrolysis following chlorpromazine ingestion complicated by SIADH." Postgrad Med J 72 (1996): 186-9. [PMID: 8731716]
290	Steinhoff BJ, Stoll KD, Stodieck SR, Paulus W "Hyponatremic coma under oxcarbazepine therapy." Epilepsy Res 11 (1992): 67-70. [PMID: 1563340]
291	Isojarvi JI, Huuskonen UE, Pakarinen AJ, Vuolteenaho O, Myllyla VV "The regulation of serum sodium after replacing carbamazepine with oxcarbazepine." Epilepsia 42 (2001): 741-5. [PMID: 11422328]
292	Okamoto M, Nako Y, Tachibana A, et al "Efficacy of phenytoin against hyponatremic seizures due to SIADH after administration of anticancer drugs in a neonate." J Perinatol 22 (2002): 247-8. [PMID: 11948390]
293	Kuroda H, Kawamura M, Hato T, et al. "Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine." Cancer Chemother Pharmacol (2007):. [PMID: 17989977]
294	Henry DA, Lawson DH, Reavey P, Renfrew S "Hyponatraemia during carbamazepine treatment." Br Med J 1 (1977): 83-4. [PMID: 832021]
295	Kuz GM, Manssourian A "Carbamazepine-induced hyponatremia: assessment of risk factors." Ann Pharmacother 39 (2005): 1943-6. [PMID: 16189283]
296	Robson WL, Leung AK "Hyponatraemia following desmopressin." BMJ 307 (1993): 64-5. [PMID: 8343697]
297	Parker WA "Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion." Drug Intell Clin Pharm 18 (1984): 890-4. [PMID: 6499653]
298	Ananth J, Lin KM "Siadh: a serious side effect of psychotropic drugs." Int J Psychiatry Med 16 (1986): 401-7. [PMID: 3557811]
299	Rider JM, Mauger TF, Jameson JP, Notman DD "Water handling in patients receiving haloperidol decanoate." Ann Pharmacother 29 (1995): 663-6. [PMID: 8520076]
300	O'Regan S, Carson S, Chesney RW, Drummond KN "Electrolyte and acid-base disturbances in the management of leukemia." Blood 49 (1977): 345-53. [PMID: 264790]
301	Wylie KR, Harris SJ, Harrop FM "Lofepramine-induced hyponatraemia." Br J Psychiatry 154 (1989): 419-20. [PMID: 2597851]
302	Woo MH, Smythe MA "Association of SIADH with selective serotonin reuptake inhibitors." Ann Pharmacother 31 (1997): 108-10. [PMID: 8997475]
303	Draper B, Berman K "Tolerability of selective serotonin reuptake inhibitors: issues relevant to the elderly." Drugs Aging 25 (2008): 501-19. [PMID: 18540689]
304	Non-steroidal anti-inflammatory drugs and the kidney. Br Med J (Clin Res Ed) 293 (1986): 202-3. [PMID: 3089448]
305	Garcia M, Miller M, Moses AM "Chlorpropamide-induced water retention in patients with diabetes mellitus." Ann Intern Med 75 (1971): 549-54. [PMID: 5094069]
306	Woster P, Carrazana EJ "Oxcarbazepine and hyponatremia." Am J Health Syst Pharm 59 (2002): 467. [PMID: 11887415]
307	Jackson C, Carson W, Markowitz J, Mintzer J "SIADH associated with fluoxetine and sertraline therapy." Am J Psychiatry 152 (1995): 809-10. [PMID: 7726326]
308	Bissett D Cornford EJ Sokal M "Hyponatraemia following cisplatin chemotherapy." Acta Oncol 28 (1989): 823. [PMID: 2611035]
309	Matuk F, Kalyanaraman K "Inappropriate ADH secretion." Arch Neurol 34 (1977): 725. [PMID: 911246]
310	Kato A, Sugiura T, Yamamoto T, et al "Water intoxication induced by low-dose oral cyclophosphamide in a patient with anti-neutrophil cytoplasmic antibody-related glomerulonephritis." NDT Plus 1 (2008): 286-8. [PMID: 18795141]
311	Flint AJ, Crosby J, Genik JL "Recurrent hyponatremia associated with fluoxetine and paroxetine." Am J Psychiatry 153 (1996): 134. [PMID: 8540575]
312	Leung M, Remick R "Sertraline-associated hyponatremia." Can J Psychiatry 40 (1995): 497-8. [PMID: 8681276]
313	Bluff DD, Oji N "SIADH in a patient receiving sertraline." Ann Intern Med 123 (1995): 811. [PMID: 7574211]
314	Otsuka F, Hayashi Y, Ogura T, et al "Syndrome of inappropriate secretion of antidiuretic hormone following intra-thoracic cisplatin." Intern Med 35 (1996): 290-4. [PMID: 8739784]
315	Nagappa M, Bhat RR, Sudeep K, Mishra SK, Badhe AS, Hemavathi B "Vincrisitine-induced acute life-threatening hyponatremia resulting in seizure and coma." Indian J Crit Care Med 13 (2009): 167-8. [PMID: 20040817]
316	DeFronzo RA, Colvin OM, Braine H, Robertson GL, Davis PJ "Proceedings: cyclophosphamide and the kidney." Cancer 33 (1974): 483-91. [PMID: 4812765]
317	Baliga RR, McHardy KC. Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy [published correction appears in Br J Clin Pract 1993 May-Jun;47(3):119].?Br J Clin Pract. 1993;47(2):62-63. [PMID: 8334062]
318	Lane RM "SSRIs and hyponatraemia." Br J Clin Pract 51 (1997): 144-6. [PMID: 9293054]
319	Zavagli G Ricci G Tataranni G Mapelli G Abbasciano V "Life-threatening hyponatremia caused by vinblastine." Med Oncol Tumor Pharmacother 5 (1988): 67-9. [PMID: 2452936]
320	Boyd IW "Hyponatremia with venlafaxine." Ann Pharmacother 32 (1998): 981. [PMID: 9762390]
321	Ljung R "Use of desmopressin and concomitant use of potentially interacting drugs in elderly patients in Sweden." Eur J Clin Pharmacol (2008):. [PMID: 18180913]
322	Roxanas MG "Mirtazapine-induced hyponatraemia." Med J Aust 179 (2003): 453-4. [PMID: 14558878]
323	Iyer AV, Krasnow SH, Dufour DR, Arcenas AS "Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer." Clin Lung Cancer 5 (2003): 187-9. [PMID: 14667276]
324	Ayonrinde OT, Sanfilippo FM "SSRI antidepressants and SIADH." Aust N Z J Psychiatry 31 (1997): 306-7. [PMID: 9140643]
325	Product Information. Pitressin (vasopressin). Parke-Davis, Morris Plains, NJ.
326	Ritch PS "Cis-dichlorodiammineplatinum II-induced syndrome of inappropriate secretion of antidiuretic hormone." Cancer 61 (1988): 448-50. [PMID: 2827877]
327	Hwang AS, Magraw RM "Syndrome of inappropriate secretion of antidiuretic hormone due to fluoxetine." Am J Psychiatry 146 (1989): 399. [PMID: 2784038]
328	Davison P, Wardrope J "Acute amitriptyline withdrawal and hyponatraemia. A case report." Drug Saf 8 (1993): 78-80. [PMID: 8471189]
329	Thornton SL, Resch DS "SIADH associated with sertraline therapy." Am J Psychiatry 152 (1995): 809. [PMID: 7726325]
330	Stuart MJ, Cuaso C, Miller M, Oski FA "Syndrome of recurrent increased secretion of antidiuretic hormone following multiple doses of vincristine." Blood 45 (1975): 315-20. [PMID: 1054263]
331	Aasen G, Frey HM "Excessive sensitivity to the hyponatremic effect of chlorpropamide in a patient with diabetes mellitus and anterior pituitary insufficiency." Acta Med Scand 208 (1980): 233-6. [PMID: 7435266]
332	Masood GR, Karki SD, Patterson WR "Hyponatremia with venlafaxine." Ann Pharmacother 32 (1998): 49-51. [PMID: 9475820]
333	Moses AM, Howanitz J, van Gemert M, Miller M "Clofibrate-induced antidiuresis." J Clin Invest 52 (1973): 535-42. [PMID: 4685079]
334	Zawada ET "Renal consequences of nonsteroidal antiinflammatory drugs." Postgrad Med J 71 (1982): 223-30. [PMID: 7041104]
335	Harlow PJ, DeClerck YA, Shore NA, Ortega JA, Carranza A, Heuser E "A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapy." Cancer 44 (1979): 896-8. [PMID: 476599]
336	Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S "Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review." Epilepsia 35 (1994): 181-8. [PMID: 8112243]
337	Shang CY, Soong WT, Lin HN "Hypokalemia with venlafaxine." J Clin Psychiatry 63 (2002): 1049-50. [PMID: 12469691]
338	Product Information. Stimate (desmopressin). Forest Pharmaceuticals, St. Louis, MO.
339	Cinotti GA, Stirati G, Ruggiero F "Abnormal water retention and symptomatic hyponatraemia in idiopathic diabetes insipidus during chlorpropamide therapy." Postgrad Med J 48 (1972): 107-11. [PMID: 5015114]
340	Henkin Y, Kaplan Z, Alkan M "Psychiatric presentation of hyponatremia associated with the use of amitriptyline: a report of two cases." Isr J Med Sci 25 (1989): 587-9. [PMID: 2807860]
341	Colgate R "Hyponatraemia and inappropriate secretion of antidiuretic hormone associated with the use of imipramine." Br J Psychiatry 163 (1993): 819-22. [PMID: 8306129]
342	Nisbet P "Chlorpropamide-induced hyponatraemia." Br Med J 1 (1977): 904. [PMID: 851776]
343	Adlakha A, Manocha AP, Bechard DL "Imipramine-induced syndrome of inappropriate antidiuretic hormone secretion." South Med J 84 (1991): 1507-9. [PMID: 1749990]
344	Kessler J, Samuels SC "Sertraline and hyponatremia." N Engl J Med 335 (1996): 524. [PMID: 8676965]
345	Twardowschy CA, Bertolucci CB, Gracia Cde M, Brandao MA "Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report." Arq Neuropsiquiatr 64 (2006): 142-5. [PMID: 16622573]
346	Zalin AM, Hutchinson CE, Jong M, Matthews K "Hyponatraemia during treatment with chlorpropamide and Moduretic (amiloride plus hydrochlorothiazide)." Br Med J (Clin Res Ed) 289 (1984): 659. [PMID: 6434028]
347	Glue P, Banfield CR, Colucci RD, Perhach JL "Warfarin-felbamate interaction." Ann Pharmacother 28 (1994): 1412-3. [PMID: 7696739]
348	Thijssen HH, Flin ois JP, Beaune PH "Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes." Drug Metab Dispos 28 (2000): 1284-90. [PMID: 11038154]
349	Tisdel KA, Israel DS, Kolb KW "Warfarin-felbamate interaction: first report." Ann Pharmacother 28 (1994): 805. [PMID: 7919574]
350	Product Information. Methergine (methylergonovine). Novartis Pharmaceuticals, East Hanover, NJ.
351	Belcastro V, Costa C, Striano P "Levetiracetam-associated hyponatremia." Seizure 17 (2008): 389-90. [PMID: 18584781]
352	Gandhi S, McArthur E, Mamdani MM, et.al "Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies." Epilepsia 57 (2016): 2067-79. [PMID: 27896804]
353	Product Information. Savella (milnacipran). Forest Pharmaceuticals, St. Louis, MO.
354	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
355	Product Information. Pristiq (desvenlafaxine). Wyeth Laboratories, Philadelphia, PA.
356	Product Information. Tegretol (carbamazepine). Novartis Pharmaceuticals, East Hanover, NJ.
357	Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
358	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
359	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
360	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
361	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
362	Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
363	Patel KR, Meesala A, Stanilla JK "Sodium valproate-induced hyponatremia: a case report." Prim Care Companion J Clin Psychiatry 12 (2010): epub. [PMID: 21274365]
364	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
365	Falhammar H, Lindh JD, Calissendorff J, et.al "Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: A population-based case-control study." Seizure 59 (2018): 28-33. [PMID: 29730273]
366	Bavbek N, Alkan R, Uz E, Kaftan O, Akcay A "Hyponatremia associated with sodium valproate in a 22-year-old male." Nephrol Dial Transplant 23 (2008): epub. [PMID: 17913733]
367	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
368	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
369	Product Information. Ellence (epirubicin) Pharmacia and Upjohn, Kalamazoo, MI.
370	Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
371	Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
372	Baciewicz AM, Self TH "Rifampin drug interactions." Arch Intern Med 144 (1984): 1667-71. [PMID: 6380442]
373	Back DJ, Breckenridge AM, Crawford FE, et al. "The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women." Contraception 21 (1980): 135-43. [PMID: 7189454]
374	Barditch-Crovo P, Trapnell CB, Ette E, et al "The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive." Clin Pharmacol Ther 65 (1999): 428-38. [PMID: 10223781]
375	Bolt HM, Bolt M, Kappus H "Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man." Acta Endocrinol (Copenh) 85 (1977): 189-97. [PMID: 577076]
376	Borcherding SM, Baciewicz AM, Self TH "Update on rifampin drug interactions." Arch Intern Med 152 (1992): 711-6. [PMID: 1558427]
377	Cote J "Interaction of griseofulvin and oral contraceptives." J Am Acad Dermatol 22 (1990): 124-5. [PMID: 2298948]
378	Curran MA "Drug interactions with the pill." Med J Aust 144 (1986): 670-1. [PMID: 3086681]
379	Dickinson BD, Altman RD, Nielsen NH, Sterling ML "Drug interactions between oral contraceptives and antibiotics." Obstet Gynecol 98(5 Pt 1) (2001): 853-60. [PMID: 11704183]
380	Durr D, Stieger B, KullakUblick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K "St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4." Clin Pharmacol Ther 68 (2000): 598-604. [PMID: 11180019]
381	Gorski JC, Hamman MA, Wang Z, Vasvada N, Huang S, Hall SD "The effect of St. John's wort on the efficacy of oral contraception." Clin Pharmacol Ther 71 (2002): P25. [PMID: 14663455]
382	Hall SD, Wang Z, Huang SM, et al. "The interaction between St John's wort and an oral contraceptive." Clin Pharmacol Ther 74 (2003): 525-35. [PMID: 14663455]
383	Halpenny O, Bye A, Cranny A, Feely J, Daly PA "Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate." Med Oncol Tumor Pharmacother 7 (1990): 241-7. [PMID: 2149401]
384	LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallee F, Narang PK "Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone." J Clin Pharmacol 38 (1998): 1042-50. [PMID: 9824786]
385	McDaniel PA, Caldroney RD "Oral contraceptives and griseofulvin interaction." Drug Intell Clin Pharm 20 (1986): 384. [PMID: 3709350]
386	Michalets EL "Update: clinically significant cytochrome P-450 drug interactions." Pharmacotherapy 18 (1998): 84-112. [PMID: 9469685]
387	Mumford JP "Letter: Drugs affecting oral contraceptives." Br Med J 2 (1974): 333-4. [PMID: 4827122]
388	Nocke-finck L "Effects of rifampicin on menstral cycle and on estrogen excretion in patients taking oral contraceptives." JAMA 226 (1973): 378. [PMID: 4580141]
389	Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J "Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial." Br J Clin Pharmacol 56 (2003): 683-90. [PMID: 14616430]
390	Product Information. Premarin (conjugated estrogens). Wyeth-Ayerst Laboratories, Philadelphia, PA.
391	Murphy PA. St. John's wort and oral contraceptives: reasons for concern?.?J Midwifery Womens Health. 2002;47(6):447-450. doi:10.1016/s1526-9523(02)00321-5. [PMID: 12484666]
392	Skolnick JL, Stoler BS, Katz DB, Anderson WH "Rifampin, oral contraceptives, and pregnancy." JAMA 236 (1976): 1382. [PMID: 989097]
393	Strayhorn VA, Baciewicz AM, Self TH "Update on rifampin drug interactions, III." Arch Intern Med 157 (1997): 2453-8. [PMID: 9385296]
394	Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 55 (2003): 112-113. [PMID: 12534648]
395	van Dijke CP, Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J (Clin Res Ed) 288 (1984): 1125-6. [PMID: 2143563]
396	Venkatesan K "Pharmacokinetic drug interactions with rifampicin." Clin Pharmacokinet 22 (1992): 47-65. [PMID: 1559307]
397	Weaver K, Glasier A "Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review." Contraception 59 (1999): 71-8. [PMID: 10361620]
398	Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J 288 (1984): 1125-6. [PMID: 6424759]
399	Weisberg E "Interactions between oral contraceptives and antifungals antibacterials - Is contraceptive failure the result?." Clin Pharmacokinet 36 (1999): 309-13. [PMID: 10384856]
400	Zachariassen RD "Loss of oral contraceptive efficacy by concurrent antibiotic administration." Women Health 22 (1994): 17-26. [PMID: 7900401]
401	Lundgren S, Lonning PE, Aakvaag A, Kvinnsland S, Lnning PE "Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer." Cancer Chemother Pharmacol 27 (1990): 101-5. [PMID: 2249324]
402	Product Information. Lunesta (eszopiclone). Sepracor Inc, Marlborough, MA.
403	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
404	Gilman AG, Rall TW, Nies AS, Taylor P, eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 8th ed." New York, NY: Pergamon Press Inc. (1990):.
405	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
406	Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
407	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
408	Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
409	Glue P, Banfield CR, Perhach JL, Mather GG, Racha JK, Levy RH "Pharmacokinetic interactions with felbamate.In vitro-in vivo correlation." Clin Pharmacokinet 33 (1997): 214-24. [PMID: 9314612]
410	Product Information. Carbatrol (carbamazepine). Athena Neurosciences Inc, South San Francisco, CA.
411	Product Information. Dilantin (phenytoin). Parke-Davis, Morris Plains, NJ.
412	Product Information. Phenobarbital (phenobarbital). Lilly, Eli and Company, Indianapolis, IN.
413	Product Information. Rifadin (rifampin). Hoechst Marion-Roussel Inc, Kansas City, MO.
414	Product Information. Rifamate (rifampin). Hoechst Marion-Roussel Inc, Kansas City, MO.
415	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
416	Product Information. Otezla (apremilast). Celgene Corporation, Summit, NJ.
417	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
418	Product Information. Nuvigil (armodafinil). Cephalon Inc, West Chester, PA.
419	Product Information. Provigil (modafinil). Cephalon, Inc, West Chester, PA.
420	Product Information. Coartem (artemether-lumefantrine). Novartis Pharmaceuticals, East Hanover, NJ.
421	Bullman J, Nicholls A, Van Landingham K, et al. "Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers." Epilepsia 52 (2011): 1351-8. [PMID: 21635243]
422	Gerber JG, Rosenkranz SL, Fichtenbaum CJ, et al. "Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study." J Acquir Immune Defic Syndr 39 (2005): 307-12. [PMID: 15980690]
423	Khandwala HM "Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin." South Med J 99 (2006): 1385-7. [PMID: 17233196]
424	Murphy MJ, Dominiczak MH "Efficacy of statin therapy: possible effect of phenytoin." Postgrad Med J 75 (1999): 359-60. [PMID: 10435174]
425	Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
426	Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
427	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
428	Pithavala YK, Tortorici M, Toh M, et al "Effect of rifampin on the pharmacokinetics of axitinib (AG-013736) in Japanese and Caucasian healthy volunteers." Cancer Chemother Pharmacol 65 (2010): 563-70. [PMID: 19603168]
429	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
430	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
431	Product Information. Biktarvy (bictegravir/emtricitabine/tenofovir). Gilead Sciences, Foster City, CA.
432	Product Information. Viread (tenofovir). Gilead Sciences, Foster City, CA.
433	Product Information. Incivek (telaprevir). Vertex Pharmaceuticals, Cambridge, MA.
434	Product Information. Victrelis (boceprevir). Schering-Plough Corporation, Kenilworth, NJ.
435	Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
436	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
437	Product Information. Zulresso (brexanolone). Sage Therapeutics, Inc., Cambridge, MA.
438	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
439	Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
440	Product Information. Cabometyx (cabozantinib). Exelixis Inc, S San Francisco, CA.
441	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
442	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
443	Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
444	Product Information. Vraylar (cariprazine). Actavis Pharma, Inc., Parsippany, NJ.
445	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
446	Hedaya MA, El-Afify DR, El-Maghraby GM "The effect of ciprofloxacin and clarithromycin on sildenafil oral bioavailability in human volunteers." Biopharm Drug Dispos 27 (2006): 103-10. [PMID: 16372380]
447	Herrlin K, Segerdahl M, Gustafsson LL, Kalso E "Methadone, ciprofloxacin, and adverse drug reactions." Lancet 356 (2000): 2069-70. [PMID: 11145498]
448	McLellan RA, Drobitch RK, Monshouwer M, Renton KW "Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human." Drug Metab Dispos 24 (1996): 1134-8. [PMID: 8894516]
449	Product Information. Pletal (cilostazol). Otsuka American Pharmaceuticals, Rockville, MD.
450	Sawant RD "Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin." Can J Clin Pharmacol 16 (2009): e78-9. [PMID: 19151423]
451	Shahzadi A, Javed I, Aslam B, et al. "Therapeutic effects of ciprofloxacin on the pharmacokinetics of carbamazepine in healthy adult male volunteers." Pak J Pharm Sci 24 (2011): 63-8. [PMID: 21190921]
452	Sriwiriyajan S, Samaeng M, Ridtitid W, Mahatthanatrakul W, Wongnawa M "Pharmacokinetic interactions between ciprofloxacin and itraconazole in healthy male volunteers." Biopharm Drug Dispos 32 (2011): 168-74. [PMID: 21360715]
453	Suri A, Bramer SL "Effect of omeprazole on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 53-9. [PMID: 10702887]
454	Suri A, Forbes WP, Bramer SL "Effects of CYP3A inhibition on the metabolism of cilostazol." Clin Pharmacokinet 37 (1999): 61-8. [PMID: 10702888]
455	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
456	Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
457	Cerner Multum, Inc. "Canadian Product Information.".
458	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
459	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
460	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
461	Aronson JK, Grahame-Smith DG "Clinical pharmacology: adverse drug interactions." Br Med J 282 (1981): 288-91. [PMID: 6779990]
462	Baker SD "Drug interactions with the taxanes." Pharmacotherapy 17(5 Pt 2) (1997): s126-32. [PMID: 9322879]
463	Komoroski BJ, Parise RA, Egorin MJ, Strom SC, Venkataramanan R "Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures." Clin Cancer Res 11(19 Pt 1) (2005): 6972-9. [PMID: 16203790]
464	McInnes GT, Brodie MJ "Drug interactions that matter: a critical reappraisal." Drugs 36 (1988): 83-110. [PMID: 3063497]
465	Product Information. Taxotere (docetaxel). Rhone-Poulenc Rorer, Collegeville, PA.
466	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
467	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
468	Product Information. Adriamycin PFS (doxorubicin). Pharmacia and Upjohn, Kalamazoo, MI.
469	Product Information. Doxil (doxorubicin liposomal). Sequis Pharmaceuticals Inc, Menlo Park, CA.
470	Kaytser V, Zhang P. Non-interacting, Non-opioid, and Non-barbiturate Containing Acute Medication Combinations in Headache: A Pilot Combinatorics Approach Based on DrugBank Database.?Front Neurol. 2021;12:632830. [PMID: 33679591]
471	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
472	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
473	Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
474	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
475	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
476	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
477	Chan BSH, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG "Serotonin syndrome resulting from drug interactions." Med J Aust 169 (1998): 523-5. [PMID: 9861909]
478	Corkeron MA "Serotonin syndrome - a potentially fatal complication of antidepressant therapy." Med J Aust 163 (1995): 481-2. [PMID: 7476638]
479	Laird LK "Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder." Psychopharmacol Bull 32 (1996): 569-78. [PMID: 8993077]
480	Lane R, Baldwin D "Selective serotonin reuptake inhibitor--induced serotonin syndrome: review." J Clin Psychopharmacol 17 (1997): 208-21. [PMID: 9169967]
481	Martin TG "Serotonin syndrome." Ann Emerg Med 28 (1996): 520-6. [PMID: 8909274]
482	Mills KC "Serotonin syndrome: A clinical update." Crit Care Clin 13 (1997): 763. [PMID: 9330840]
483	Nierenberg DW, Semprebon M "The central nervous system serotonin syndrome." Clin Pharmacol Ther 53 (1993): 84-8. [PMID: 8257462]
484	Nijhawan PK, Katz G, Winter S "Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission." Crit Care Med 24 (1996): 1086-9. [PMID: 8681579]
485	Sternbach H "The serotonin syndrome." Am J Psychiatry 148 (1991): 705-13. [PMID: 2035713]
486	Product Information. Spravato (esketamine). Janssen Pharmaceuticals, Titusville, NJ.
487	Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
488	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
489	Product Information. Aromasin (exemestane) Pharmacia & Upjohn, Kalamazoo, MI.
490	Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
491	Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
492	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
493	Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
494	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
495	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
496	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
497	Harms SL, Garrard J, Schwinghammer P, Eberly LE, Chang Y, Leppik IE "Ginkgo biloba use in nursing home elderly with epilepsy or seizure disorder." Epilepsia 47 (2006): 323-9. [PMID: 16499756]
498	Kupiec T, Raj V "Fatal seizures due to potential herb-drug interactions with Ginkgo biloba." J Anal Toxicol 29 (2005): 755-8. [PMID: 16419414]
499	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
500	Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
501	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
502	Kiechel JR, Lavene D, Guerret M, Comoy E, Godin M, Fillastre JP "Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure." Eur J Clin Pharmacol 25 (1983): 463-6. [PMID: 6360692]
503	Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
504	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
505	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
506	Product Information. Cresemba (isavuconazonium). Astellas Pharma US, Inc, Deerfield, IL.
507	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
508	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
509	Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
510	Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
511	Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
512	Product Information. Ixempra (ixabepilone). Bristol-Myers Squibb, Princeton, NJ.
513	Product Information. Ninlaro (ixazomib). Takeda Pharmaceuticals America, Lincolnshire, IL.
514	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
515	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
516	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
517	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
518	Product Information. Dayvigo (lemborexant). Eisai Inc, Woodcliff Lake, NJ.
519	Berg MJ, Fischer LJ, Rivey MP, Vern BA, Lantz RK, Schottelius DD "Phenytoin and folic acid interaction: a preliminary report." Ther Drug Monit 5 (1983): 389-94. [PMID: 6659012]
520	Katz M "Potential danger of self-medication with folic acid." N Engl J Med 289 (1973): 1095. [PMID: 4742232]
521	Furlanut M, Benetello P, Avogaro A, Dainese R "Effects of folic acid on phenytoin kinetics in healthy subjects." Clin Pharmacol Ther 24 (1978): 294-7. [PMID: 688723]
522	Product Information. Tradjenta (linagliptin). Boehringer Ingelheim, Ridgefield, CT.
523	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
524	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
525	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
526	Bruderer S, Aanismaa P, Homery MC, et al. "Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist." AAPS J 14 (2012): 68-78. [PMID: 22189899]
527	Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
528	Dutreix C, Munarini F, Lorenzo S, Roesel J, Wang Y "Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers." Cancer Chemother Pharmacol 72 (2013): 1223-34. [PMID: 24085261]
529	Product Information. Rydapt (midostaurin). Novartis Pharmaceuticals, East Hanover, NJ.
530	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
531	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
532	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
533	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
534	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
535	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
536	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
537	Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
538	Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
539	Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
540	Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
541	Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
542	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
543	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
544	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
545	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
546	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
547	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
548	Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
549	Product Information. Cylert (pemoline). Abbott Pharmaceutical, Abbott Park, IL.
550	Gidal BE, Zupanc ML "Potential pharmacokinetic interaction between felbamate and phenobarbital." Ann Pharmacother 28 (1994): 455-8. [PMID: 8038465]
551	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
552	Bittencourt PR, Gracia CM, Martins R, et al "Phenytoin and carbamazepine decrease oral bioavailability of praziquantel." Neurology 42 (1992): 492-6. [PMID: 1549207]
553	Product Information. Biltricide (praziquantel). Bayer, West Haven, CT.
554	Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M "Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers." Clin Pharmacol Ther 72 (2002): 505-13. [PMID: 12426514]
555	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
556	Gilead Sciences, Inc "About Remdesivir.".
557	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
558	Product Information. Edurant (rilpivirine). Tibotec Pharmaceuticals, Titusville, NJ.
559	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
560	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
561	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
562	Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
563	Product Information. Onglyza (saxagliptin). Bristol-Myers Squibb, Princeton, NJ.
564	Product Information. Rapaflo (silodosin). Watson Pharmaceuticals, Corona, CA.
565	Product Information. VESIcare (solifenacin). GlaxoSmithKline, Research Triangle Park, NC.
566	Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
567	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
568	Product Information. Belsomra (suvorexant). Merck & Company Inc, Whitehouse Station, NJ.
569	Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
570	Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
571	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
572	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
573	Product Information. Torisel (temsirolimus). Wyeth-Ayerst Laboratories, Philadelphia, PA.
574	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
575	Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
576	Teng R, Mitchell P, Butler K "Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects." Eur J Clin Pharmacol 69 (2013): 877-83. [PMID: 23093043]
577	Weeks P, Sieg A, Vahdat K, Raissi F, Nathan S "Improved ticagrelor antiplatelet effect on discontinuation of phenytoin." Ann Pharmacother 48 (2014): 644-7. [PMID: 24477376]
578	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
579	Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
580	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
581	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
582	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
583	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
584	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
585	Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
586	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
587	Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
588	Bolton AE, Peng B, Hubert M, et al. "Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects." Cancer Chemother Pharmacol 53 (2004): 102-6. [PMID: 14605865]
589	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
590	Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
591	Crews KR, Stewart CF, Jones-Wallace D, et al "Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy." Clin Cancer Res 8 (2002): 2202-9. [PMID: 12114421]
592	Di YM, Li CG, Xue CC, Zhou SF "Clinical drugs that interact with St. John's wort and implication in drug development." Curr Pharm Des 14 (2008): 1723-42. [PMID: 18673195]
593	Friedman HS, Petros WP, Friedman AH, et al "Irinotecan therapy in adults with recurrent or progressive malignant glioma." J Clin Oncol 17 (1999): 1516-25. [PMID: 10334539]
594	Innocenti F, Undevia SD, Ramirez J, et al. "A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital." Clin Pharmacol Ther 76 (2004): 490-502. [PMID: 15536463]
595	Kuhn JG "Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report." Oncology (Williston Park 16(8 Suppl 7) (2002): 33-40. [PMID: 12199631]
596	Hu ZP, Yang XX, Chen X, et al. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.?Curr Drug Metab. 2007;8(2):157-171. [PMID: 17305494]
597	Mathijssen RH, Verweij J, De Bruijn P, Loos WJ, Sparreboom A "Effects of St. John's Wort on Irinotecan Metabolism." J Natl Cancer Inst 94 (2002): 1247-9. [PMID: 12189228]
598	Minami H, Lad TE, Nicholas MK, Vokes EE, Ratain MJ "Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies." Clin Cancer Res 5 (1999): 1325-30. [PMID: 10389915]
599	Murry DJ, Cherrick I, Salama V, et al. "Influence of phenytoin on the disposition of irinotecan: a case report." J Pediatr Hematol Oncol 24 (2002): 130-3. [PMID: 11990699]
600	Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
601	Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
602	Hofland KF, Hansen S, Sorensen M, et al. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.?Acta Oncol. 2014;53(7):939-944. [PMID: 24456504]
603	Santos A, Zanetta S, Cresteil T, et al "Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans." Clin Cancer Res 6 (2000): 2012-20. [PMID: 10815927]
604	Yonemori K, Takeda Y, Toyota E, Kobayashi N, Kudo K "Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer." Int J Clin Oncol 9 (2004): 206-9. [PMID: 15221608]
605	Zamboni WC, Gajjar AJ, Heideman RL, et al "Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma." Clin Cancer Res 4 (1998): 783-9. [PMID: 9533548]
606	Kobayashi K, Mimura N, Fujii H, et al "Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate." Clin Cancer Res 6 (2000): 3297-303. [PMID: 10955816]
607	Product Information. Provera (medroxyprogesterone). Pharmacia and Upjohn, Kalamazoo, MI.
608	Lambertsen CJ, Wendel H, Longenhagen JB "The separate and combined respiratory effects of chlorpromazine and meperidine in normal men controlled at 46 mm Hg alveolar pCO2." J Pharmacol Exp Ther 131 (1961): 381-93. [PMID: 13758472]
609	Hoffman JC, Smith TC "The respiratory effects of meperidine and propiomazine in man." Anesthesiology 32 (1970): 325-31. [PMID: 4392394]
610	Stambaugh JE, Wainer IW "Drug interaction: meperidine and chlorpromazine, a toxic combination." J Clin Pharmacol 21 (1981): 140-6. [PMID: 7240435]
611	Product Information. Meperidine Hydrochloride Injection, USP (meperidine) Astra-Zeneca Pharmaceuticals, Wilmington, DE.
612	Product Information. Demerol (meperidine). Sanofi Winthrop Pharmaceuticals, New York, NY.
613	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
614	Product Information. Singulair (montelukast). Merck & Co, Inc, West Point, PA.
615	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
616	Product Information. Patanase (olopatadine nasal). Alcon Laboratories Inc, Fort Worth, TX.
617	Fabre C, Criddle J, Nolder D, Klein JL "Recrudescence of imported falciparum malaria after quinine therapy: potential drug interaction with phenytoin." Trans R Soc Trop Med Hyg 99 (2005): 871-3. [PMID: 16099004]
618	Product Information. Qualaquin (quinine). AR Scientific Inc, Philadelphia, PA.
619	Pukrittayakamee S, Prakongpan S, Wanwimolruk S, Clemens R, Looareesuwan S, White NJ "Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria." Antimicrob Agents Chemother 47 (2003): 1509-1513. [PMID: 12709315]
620	Twum-Barima Y, Carruthers SG "Quinidine-rifampin interaction." N Engl J Med 304 (1981): 1466-9. [PMID: 7231477]
621	Wanwimolruk S, Kang W, Coville PF, Viriyayudhakorn S, Thitiarchakul S "Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man." Br J Clin Pharmacol 40 (1995): 87-91. [PMID: 8527275]
622	Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
623	Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT "Rifampin decreases the plasma concentrations and effects of repaglinide." Clin Pharmacol Ther 68 (2000): 495-500. [PMID: 11103752]
624	Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
625	Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
626	Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
627	Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
628	Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
629	Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
630	Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
631	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
632	Product Information. Adcirca (tadalafil). United Therapeutics Corporation, Silver Spring, MD.
633	Product Information. Cialis (tadalafil). Lilly, Eli and Company, Indianapolis, IN.
634	Biochem Pharmacol "Variable contribution of cytochromes P450 2D6, 2C9, and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes." Biochem Pharmacol 53 (1997): 171-8. [PMID: 9037249]
635	Kivisto KT, Villikka K, Nyman L, Anttila M, Neuvonen PJ "Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin." Clin Pharmacol Ther 64 (1998): 648-54. [PMID: 9871429]
636	Lien EA, Anker G, Lonning PE, et al "Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide." Cancer Res 50 (1990): 5851-7. [PMID: 2393854]
637	Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
638	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
639	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
640	Berthou F, Dreano Y, Belloc C, Kangas L, Gautier JC, Beaune P "Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes." Biochem Pharmacol 47 (1994): 1883-95. [PMID: 8204106]
641	Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
642	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
643	Hellmann A, Rule S, Walewski J, et al. "Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or Non-Hodgkin's lymphoma." Clin Pharmacokinet 50 (2011): 781-91. [PMID: 22087865]
644	Pekol T, Daniels JS, Labutti J, et al "Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites." Drug Metab Dispos 33 (2005): 771-7. [PMID: 15764713]
645	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
646	Uttamsingh V, Lu C, Miwa GT, Gan LS "Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4 to the hepatic metabolism of teh protosome inhibitor bortezomib." Drug Metab Dispos 33 (2005): 1723-8. [PMID: 16103134]
647	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
648	Product Information. Aczone (dapsone topical). QLT USA, Inc, Fort Collins, CO.
649	Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
650	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
651	Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
652	Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
653	Heinonen J, Takki S, Jarho L "Plasma lidocaine levels in patients treated with potential inducers of microsomal enzymes." Acta Anaesthesiol Scand 14 (1970): 89-95. [PMID: 5428253]
654	Perucca E, Richens A "Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients." Br J Clin Pharmacol 8 (1979): 21-31. [PMID: 552293]
655	Perucca E, Ruprah M, Richens A, Park BK, Betteridge DJ, Hedges AM "Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects." Br J Clin Pharmacol 12 (1981): 592-6. [PMID: 6117310]
656	Reichel C, Skodra T, Nacke A, Spengler U, Sauerbruch T "The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans." Br J Clin Pharmacol 46 (1998): 535-9. [PMID: 9862241]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence